Allergic rhinitis

ALLERG_RHINITIS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

16227

4. Check minimum number of events

None

16227

5. Include endpoints

None

16227

6. Filter based on genotype QC (FinnGen only)

16227

Control definitions (FinnGen only)

Control exclude
ASTHMA_ALLERG, ST19_ADVER_EFFEC_NOT_ELSEW_CLASSIFIED

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 167729 82728 84603
Only index persons 149469 76134 73335
Unadjusted period prevalence (%)
Whole population 2.36 2.37 2.36
Only index persons 2.80 2.80 2.80
Median age at first event (years)
Whole population 19.13 24.99 13.33
Only index persons 21.15 27.10 14.98

-FinnGen-

Key figures

All Female Male
Number of individuals 16227 10980 5247
Unadjusted period prevalence (%) 3.28 3.74 2.31
Median age at first event (years) 34.54 34.86 33.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
14340
Matched controls
142309
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R06AX27
ATC
desloratadine; oral
4.1
323.0
7200
27983
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
5.5
323.0
1360
2646
R03AC02
ATC
salbutamol; inhalant
5.0
323.0
10815
54193
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.3
323.0
4229
21573
J45.1
ICD-10 Finland
Nonallergic asthma
4.0
323.0
1448
3927
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
4.4
323.0
1320
3210
4779A
ICD-9 Finland
Allergic rhinitis, Cause unspecified
+∞
323.0
1364
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
5.7
323.0
5115
12536
R01AC01
ATC
cromoglicic acid; nasal
5.5
323.0
1363
2686
R03BA01
ATC
beclometasone; inhalant
3.7
323.0
2882
8978
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.9
323.0
2697
8067
XG410
NOMESCO Finland
Flow-volume spirometry
6.4
323.0
1008
1666
R01BA52
ATC
pseudoephedrine, combinations; oral
2.6
323.0
5125
25190
R03AK07
ATC
formoterol and budesonide; inhalant
3.0
323.0
3695
14960
R06AE07
ATC
cetirizine; oral
4.2
323.0
9601
46019
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
6.6
323.0
3420
6423
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
78.6
323.0
7799
2129
J45
ICD-10 Finland
Asthma
4.3
323.0
2295
6059
J01FA10
ATC
azithromycin; systemic
2.1
323.0
9736
71885
V01AA05
ATC
tree pollen; parenteral
19.9
323.0
516
267
R01AD09
ATC
mometasone; nasal
4.1
323.0
9619
47219
J30.1
ICD-10 Finland
Allergic rhinitis due to pollen
+∞
323.0
312
*
R06AX22
ATC
ebastine; oral
3.8
323.0
4233
14156
R03BA02
ATC
budesonide; inhalant
4.4
323.0
4375
12955
R03BA05
ATC
fluticasone; inhalant
3.9
323.0
4430
14614
UDH02
NOMESCO Finland
Rhinopharyngoscopy
4.2
323.0
1482
3768
H02AB06
ATC
prednisolone; systemic
3.3
323.0
7977
39222
XQ800
NOMESCO Finland
Prick test
9.8
323.0
3676
4828
R06AX26
ATC
fexofenadine; oral
4.5
323.0
1880
4594
C01CA24
ATC
epinephrine; parenteral
9.9
323.0
2744
3333
R01AD08
ATC
fluticasone; nasal
4.3
323.0
6997
25749
R01AD05
ATC
budesonide; nasal
5.2
323.0
2209
4825
R01AD12
ATC
fluticasone furoate; nasal
2.9
323.0
6486
31251
R01AD01
ATC
beclometasone; nasal
3.6
323.0
3471
11509
Z51.6
ICD-10 Finland
Desensitization to allergens
300.6
323.0
1779
67
R03BA08
ATC
ciclesonide; inhalant
3.7
323.0
1708
5076
WQ000
NOMESCO Finland
Hyposensibilisation
338.9
323.0
752
23
J45.0
ICD-10 Finland
Predominantly allergic asthma
15.8
323.0
4872
4484
R03AC03
ATC
terbutaline; inhalant
3.9
323.0
3282
10074
XG474
NOMESCO Finland
Exhalation nntrogen oxide
9.2
323.0
1084
1257
J30.4
ICD-10 Finland
Allergic rhinitis, unspecified
24.6
323.0
2825
1404
J30.3
ICD-10 Finland
Other allergic rhinitis
67.4
323.0
4466
947
S01GX02
ATC
levocabastine; ophthalmic
4.1
323.0
1591
4219
J45.8
ICD-10 Finland
Mixed asthma
8.0
323.0
918
1207
J45.9
ICD-10 Finland
Asthma, unspecified
5.4
323.0
4580
11430
R03DC03
ATC
montelukast; oral
5.8
323.0
4955
11938
R96
ICPC
Asthma
4.5
323.0
1911
4688
E0000UV
ATC
NA
2.1
323.0
6317
39146
T78.4
ICD-10 Finland
Allergy, unspecified
7.7
323.0
1147
1586
J30.19
ICD-10 Finland
Pollen allergy UNS
6.3
323.0
1158
1971
S01GX01
ATC
cromoglicic acid; ophthalmic
5.1
323.0
6102
17890
R01AD11
ATC
triamcinolone; nasal
3.7
323.0
1974
5852
L20.0
ICD-10 Finland
Besnier prurigo
4.3
323.0
2259
5889
J31.0
ICD-10 Finland
Chronic rhinitis
4.5
323.0
2030
5062
R06AE09
ATC
levocetirizine; oral
4.2
323.0
4116
12439
R06AX13
ATC
loratadine; oral
3.9
323.0
4182
13565
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
4.2
323.0
1873
4906
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
3.3
323.0
5157
20540
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
5.2
319.7
1067
2166
J30.0
ICD-10 Finland
Vasomotor rhinitis
7.5
305.0
757
1044
V01AA02
ATC
grass pollen; systemic
64.9
294.6
345
54
R06.0
ICD-10 Finland
Dyspnoea
2.3
293.2
3225
15772
H02AB04
ATC
methylprednisolone; systemic
2.7
288.1
2264
9222
R03AC12
ATC
salmeterol; inhalant
5.8
280.0
848
1530
J01AA02
ATC
doxycycline; systemic
1.9
262.9
10213
80383
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.5
253.7
974
2278
R06.2
ICD-10 Finland
Wheezing
4.3
247.8
988
2397
J34.2
ICD-10 Finland
Deviated nasal septum
4.0
246.5
1065
2784
E000001
ATC
NA
2.1
246.3
3413
18333
R03AC13
ATC
formoterol; inhalant
4.6
245.2
911
2060
XQ802
NOMESCO Finland
Epicutan test
4.2
243.8
997
2477
SPAT1267
SPAT
Desensitisation
157.8
235.8
250
16
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
53.6
232.8
281
53
R03AK08
ATC
formoterol and beclometasone; inhalant
4.9
230.7
813
1737
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
11.8
229.5
439
381
J01FA06
ATC
roxithromycin; oral
1.8
227.6
5471
35925
R97
ICPC
Allergic rhinitis
5.9
227.2
677
1192
L27.2
ICD-10 Finland
Dermatitis due to ingested food
9.8
226.5
476
496
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
4.6
226.0
841
1901
3023
Kela drug reimbursment
Allergen extract of birch pollen (adults)
93.9
225.2
251
27
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.4
222.5
2097
9336
J01FA09
ATC
clarithromycin; systemic
1.8
220.2
4828
30634
D07AA02
ATC
hydrocortisone; topical
2.2
218.1
2507
12299
R05
ICD-10 Finland
Cough
2.1
217.4
2798
14442
A92
ICPC
Allergy/allergic reaction NOS
4.6
216.8
811
1842
DHB50
NOMESCO Finland
Turbinoplasty
5.4
215.6
690
1323
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
7.3
214.9
540
754
R06AX12
ATC
terfenadine; oral
3.7
211.3
988
2756
H02AB07
ATC
prednisone; oral
2.4
208.5
1946
8595
E000002
ATC
NA
2.3
205.9
2096
9672
S01GX08
ATC
ketotifen; ophthalmic
4.0
204.1
881
2291
J46
ICD-10 Finland
Status asthmaticus
5.9
200.9
591
1022
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
199.7
7725
57928
R01AC02
ATC
levocabastine; nasal
4.6
199.6
737
1649
R03BB04
ATC
tiotropium bromide; inhalant
3.3
199.3
1091
3445
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.9
194.3
855
2259
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
193.1
2936
16137
Z3231
NOMESCO Finland
Registered nurse
1.9
191.2
3725
22443
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
180.1
7489
56575
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
4.1
178.3
753
1915
R03BC01
ATC
cromoglicic acid; inhalant
6.4
175.9
485
770
D07AB02
ATC
hydrocortisone butyrate; topical
1.8
173.4
3843
24035
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
4.0
171.3
738
1910
R03DA04
ATC
theophylline; systemic, rectal
4.3
164.1
655
1578
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
6.8
163.8
433
649
D07AC13
ATC
mometasone; topical
1.8
162.8
3773
23846
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
4.5
160.6
610
1400
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
158.7
2357
12715
J33.8
ICD-10 Finland
Other polyp of sinus
6.2
158.7
447
730
D07AC01
ATC
betamethasone; topical
1.7
155.4
4225
27956
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.2
155.3
1776
8570
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
4.6
153.4
567
1266
DJD20
NOMESCO Finland
Plastic repair of septum of nose
3.9
150.3
659
1729
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.3
148.2
798
2474
J33.0
ICD-10 Finland
Polyp of nasal cavity
4.9
147.2
513
1077
D07AB08
ATC
desonide; topical
2.2
147.1
1602
7545
A02BC05
ATC
esomeprazole; systemic
1.6
143.1
4824
33713
R03BC03
ATC
nedocromil; inhalant
2.7
143.0
1052
4017
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.8
142.8
641
1716
R02
ICPC
Shortness of breath/dyspnoea
2.2
140.0
1535
7241
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
4.8
137.5
480
1009
A02BC02
ATC
pantoprazole; systemic
1.5
133.9
7591
59984
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
4.3
133.8
530
1265
J01DB01
ATC
cefalexin; oral
1.6
132.0
11290
98421
D11AH01
ATC
tacrolimus; topical
7.6
131.4
319
422
J01CA04
ATC
amoxicillin; systemic
1.7
131.2
11929
105670
J30.2
ICD-10 Finland
Other seasonal allergic rhinitis
19.6
127.7
197
101
J01DA01
ATC
[U] cefalexin; systemic
1.5
127.5
8240
66752
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.0
123.7
1805
9583
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
122.5
4224
29398
S01GX09
ATC
olopatadine; ophthalmic
3.8
119.0
536
1437
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
115.2
4882
35605
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
5.5
113.9
356
661
R06AX18
ATC
acrivastine; oral
3.8
113.0
502
1329
G47.3
ICD-10 Finland
Sleep apnoea
1.8
112.5
2355
14159
M25.5
ICD-10 Finland
Pain in joint
1.6
112.0
3749
25764
R06AX11
ATC
astemizole; oral
3.2
111.8
627
1997
M03BX02
ATC
tizanidine; oral
1.5
110.5
8066
66069
J02AC01
ATC
fluconazole; systemic
1.5
109.1
5554
42077
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
108.8
4261
30395
S01GX04
ATC
nedocromil; ophthalmic
4.9
106.3
364
749
SPAT1058
SPAT
PEF monitoring instruction
2.3
106.2
1072
4831
R03DC01
ATC
zafirlukast; oral
6.3
106.1
296
477
UDM02
NOMESCO Finland
Sinoscopy
4.2
106.0
423
1016
A02BC03
ATC
lansoprazole; oral
1.6
103.8
3048
20172
J01FA15
ATC
telithromycin; oral
2.0
101.9
1367
6986
364
Kela drug reimbursment
Allergen extract of birch pollen and allergen extract of grass pollen
81.5
100.9
114
14
N02BE01
ATC
paracetamol; systemic, rectal
1.5
100.2
11004
97174
M79.6
ICD-10 Finland
Pain in limb
1.5
100.0
4260
30852
T78.3
ICD-10 Finland
Angioneurotic oedema
15.6
98.6
165
106
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
98.0
4259
30952
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
97.6
2975
19836
E000007
ATC
NA
2.4
96.6
919
4017
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
7.6
95.6
231
304
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
9.2
92.6
200
219
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.6
92.2
3331
23123
N02AX02
ATC
tramadol; systemic, rectal
1.5
91.7
4439
32916
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
88.8
5445
42306
A02BC01
ATC
omeprazole; systemic
1.6
87.9
2900
19651
R51.80
ICD-10 Finland
Headache
1.7
87.2
2192
13814
N05BB01
ATC
hydroxyzine; systemic
2.2
86.3
934
4335
L20
ICD-10 Finland
Atopic dermatitis
2.9
86.2
556
1946
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.5
85.7
708
2870
G44.2
ICD-10 Finland
Tension-type headache
1.7
85.6
1835
11022
ZXC60
NOMESCO Finland
Application of heat
4.7
85.6
307
664
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.0
84.4
1167
6014
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
84.0
2909
19911
R03CC02
ATC
salbutamol; systemic
1.9
83.7
1442
8061
E000006
ATC
NA
2.2
83.5
924
4330
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
6.0
83.1
240
405
R06.5
ICD-10 Finland
Mouth breathing
2.0
83.1
1095
5535
M01AE02
ATC
naproxen; oral, rectal
1.4
82.1
7719
64583
D02AX
ATC
Other emollients and protectives
2.7
80.8
576
2146
R03AK11
ATC
formoterol and fluticasone; inhalant
3.5
79.8
393
1133
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
79.5
2128
13612
M79.1
ICD-10 Finland
Myalgia
1.7
79.0
1689
10118
ZXA10
NOMESCO Finland
Bilateral
1.7
78.9
1948
12179
M01AH05
ATC
etoricoxib; oral
1.4
78.1
7104
58848
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
77.8
4797
37023
R74
ICPC
Upper respiratory infection acute
1.4
77.4
4616
35390
J20
ICD-10 Finland
Acute bronchitis
1.9
75.9
1163
6224
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.7
75.5
1617
9685
J01DA06
ATC
[U] cefuroxime; systemic
1.7
74.7
1804
11192
N03AX12
ATC
gabapentin; oral
1.7
74.5
1664
10089
R01AC07
ATC
nedocromil; nasal
9.8
74.4
154
157
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.5
74.3
3079
21873
L50.0
ICD-10 Finland
Allergic urticaria
3.1
73.0
420
1360
D02AE01
ATC
carbamide; topical
2.1
72.4
880
4292
M54.5
ICD-10 Finland
Low back pain
1.4
72.0
4041
30514
Z71.8
ICD-10 Finland
Other specified counselling
1.5
71.3
3231
23361
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
6.3
71.3
197
315
R05
ICPC
Cough
1.5
70.3
2835
19979
J01FF01
ATC
clindamycin; systemic
1.5
70.2
3075
22062
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.5
69.9
2505
17182
T78.0
ICD-10 Finland
Anaphylactic shock due to adverse food reaction
108.3
69.7
76
7
D07CC01
ATC
betamethasone and antibiotics; topical
1.7
69.2
1554
9422
R09
ICPC
Sinus symptom/complaint
1.9
69.1
1180
6555
R03BB01
ATC
ipratropium bromide; inhalant
3.6
68.8
331
937
J32.4
ICD-10 Finland
Chronic pansinusitis
4.4
68.7
258
585
R01AD
ATC
Corticosteroids
5.6
68.7
208
373
J30
ICD-10 Finland
Vasomotor and allergic rhinitis
3.7
68.6
318
873
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
67.9
2357
16035
DHB20
NOMESCO Finland
Polypectomy of internal nose
4.9
67.8
232
478
A02BA02
ATC
ranitidine; systemic
1.6
67.0
1768
11216
R05FB02
ATC
cough suppressants and expectorants
1.4
66.8
3850
29132
XG405
NOMESCO Finland
Education on PEF monitoring
4.5
66.6
247
554
D11AX14
ATC
[U] tacrolimus; topical
7.7
65.7
157
204
D11AH02
ATC
pimecrolimus; topical
8.8
65.7
144
163
SPAT1059
SPAT
Spirometry at the office
2.4
65.2
572
2391
A07AA02
ATC
nystatin; oral
2.3
65.1
628
2756
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
64.9
2059
13693
S01GX06
ATC
emedastine; ophthalmic
4.4
63.7
241
551
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.7
63.6
449
1662
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
5.8
63.2
185
319
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
62.9
3960
30388
N03AX16
ATC
pregabalin; oral
1.5
62.7
2372
16426
R42
ICD-10 Finland
Dizziness and giddiness
1.6
62.2
2021
13500
R01AX03
ATC
ipratropium bromide; nasal
3.8
61.3
270
711
J01
ICD-10 Finland
Acute sinusitis
2.1
61.0
729
3527
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
4.9
60.6
206
422
E000003
ATC
NA
2.3
60.6
621
2801
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.6
60.4
2001
13421
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
59.8
3038
22352
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
59.7
4433
34932
49300
ICD-8 Finland
Asthma, bronchiale
3.5
59.5
291
835
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.9
59.5
999
5506
N06AX21
ATC
duloxetine; oral
1.7
59.0
1300
7820
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
4.0
58.5
244
612
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
58.4
3330
25026
J01MA14
ATC
moxifloxacin; systemic
1.9
58.2
894
4773
4939A
ICD-9 Finland
Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]
14.0
58.2
101
72
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
58.1
3811
29362
L03
ICPC
Low back symptom/complaint
1.4
57.9
2890
21164
SPAT1325
SPAT
Vaccination
1.4
57.7
3662
28049
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
57.6
1071
6108
SPAT1310
SPAT
Counselling related to known health issue
1.4
57.4
3966
30823
R5140
NOMESCO Finland
Monitoring the use of the aid
1.8
57.3
1001
5588
L01
ICPC
Neck symptom/complaint
1.6
56.6
1690
11035
XQ899
NOMESCO Finland
Other assessment of skin
9.7
56.3
117
121
501
Kela drug reimbursment
Cow's milk and / or soy protein allergy in young children
3.5
56.3
271
769
M79.7
ICD-10 Finland
Fibromyalgia
2.4
56.2
486
2016
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
56.0
2420
17196
S01GX05
ATC
lodoxamide; ophthalmic
4.1
55.9
229
566
A01AB09
ATC
miconazole; local oral
1.9
55.8
940
5184
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
55.8
2910
21474
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.6
55.7
1488
9438
R53
ICD-10 Finland
Malaise and fatigue
1.5
55.6
2287
16084
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.5
55.3
1850
12414
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.6
55.1
1626
10583
J01MA02
ATC
ciprofloxacin; systemic
1.4
55.0
3798
29467
7860A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]
8.2
55.0
126
154
SPAT1057
SPAT
Peak expiratory flow measurement
3.2
54.9
309
986
L50.9
ICD-10 Finland
Urticaria, unspecified
2.3
54.9
533
2345
M02AA07
ATC
piroxicam; topical
1.4
54.8
3428
26144
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
54.7
9884
88726
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
3.9
54.6
232
592
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
54.3
3302
25050
J37.0
ICD-10 Finland
Chronic laryngitis
2.7
54.2
383
1417
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
52.8
2900
21570
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.8
52.8
1019
5875
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
4.3
52.3
199
459
Z00.0
ICD-10 Finland
General medical examination
1.5
52.1
2193
15474
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
51.8
1824
12371
J01MA12
ATC
levofloxacin; systemic
1.6
51.7
1603
10547
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
51.7
6397
54148
J01FA01
ATC
erythromycin; systemic
1.5
51.7
2049
14272
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
51.6
1842
12531
49302
ICD-8 Finland
Asthma, Rhinitis allergica cum asthmate bronchiali
7.2
51.4
128
178
D11AX15
ATC
[U] pimecrolimus; topical
11.4
51.4
98
86
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
7.4
51.2
125
169
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.5
51.1
2214
15708
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
4.9
51.0
174
359
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
50.9
1127
6775
D07AD01
ATC
clobetasol; topical
1.6
50.8
1587
10462
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
9.5
50.7
106
111
D07BC01
ATC
betamethasone and antiseptics; topical
1.7
50.2
1228
7592
N06AX11
ATC
mirtazapine; oral
1.4
50.2
3554
27599
L50.3
ICD-10 Finland
Dermatographic urticaria
3.2
50.0
270
837
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
6.3
49.9
136
215
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
6.5
49.5
133
206
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.9
49.4
772
4140
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.7
49.3
1031
6092
A02BC04
ATC
rabeprazole; oral
1.8
49.2
948
5457
L50.8
ICD-10 Finland
Other urticaria
3.2
49.0
272
861
N06AA09
ATC
amitriptyline; systemic
1.8
48.7
915
5227
S18
ICPC
Laceration/cut
1.3
48.5
4223
33856
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.6
47.7
1364
8788
WZC30
NOMESCO Finland
Teaching
1.6
47.2
1281
8139
SPAT1263
SPAT
Sampling
1.3
47.0
5241
43513
RD211
NOMESCO Finland
NA
2.2
46.8
512
2381
H01
ICPC
Ear pain/earache
1.6
46.5
1510
10033
M01AC06
ATC
meloxicam; systemic, rectal
1.3
46.4
3691
29140
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
4.0
46.3
190
471
R75
ICPC
Sinusitis acute/chronic
2.0
46.1
626
3187
J01DC02
ATC
cefuroxime; systemic
1.9
46.0
736
3982
K52.2
ICD-10 Finland
Allergic and dietetic gastroenteritis and colitis
4.3
45.5
176
413
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.5
45.0
2017
14375
J35.0
ICD-10 Finland
Chronic tonsillitis
1.8
44.9
899
5237
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
44.9
2068
14817
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
4.5
43.9
159
350
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.8
43.8
744
4110
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.6
43.6
1145
7206
F45.8
ICD-10 Finland
Other somatoform disorders
1.7
43.5
1045
6422
R49.01
ICD-10 Finland
Functional dysphonia
2.5
43.0
354
1432
L08
ICPC
Shoulder symptom/complaint
1.5
42.9
1806
12692
R06AE08
ATC
NA
4.2
42.8
169
405
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
42.3
478
2253
K07.60
ICD-10 Finland
Snapping jaw
1.8
42.2
721
3985
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
42.2
989
6035
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.7
42.1
897
5322
J05AB01
ATC
aciclovir; systemic
1.4
42.1
2313
17114
X58
ICD-10 Finland
Exposure to other specified factors
1.5
41.8
1647
11410
R07
ICPC
Sneezing/nasal congestion
1.7
41.6
998
6129
M01AH01
ATC
celecoxib; oral (coxibs)
1.5
41.4
1616
11172
J34.1
ICD-10 Finland
Cyst and mucocele of nose and nasal sinus
3.0
41.4
244
804
XQ801
NOMESCO Finland
Intracutantest
8.0
41.3
95
118
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.6
41.2
1295
8521
R29
ICPC
Respiratory symptom/complaint other
1.8
41.1
734
4121
M70.6
ICD-10 Finland
Trochanteric bursitis
1.6
41.0
1042
6496
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
3.0
40.9
242
801
L20.8
ICD-10 Finland
Other atopic dermatitis
3.8
40.8
177
462
R01AC03
ATC
azelastine; nasal
6.7
40.5
105
156
50708
ICD-8 Finland
Hay fever, Alia definita
7.0
40.3
101
143
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
40.3
2081
15210
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
40.3
9301
84136
R21
ICPC
Throat symptom/complaint
1.3
40.2
3201
25168
Z3226
NOMESCO Finland
Physiotherapist
1.4
40.1
1918
13813
R49.08
ICD-10 Finland
Other specified dysphonia
2.8
39.9
265
947
M01AB05
ATC
diclofenac; systemic, rectal
1.3
39.9
7753
68600
L23.8
ICD-10 Finland
Allergic contact dermatitis due to other agents
5.0
39.7
131
262
J01DA08
ATC
[U] cefaclor; oral
1.4
39.4
1903
13729
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.0
39.3
515
2584
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.7
39.2
278
1034
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
39.2
1432
9750
L15
ICPC
Knee symptom/complaint
1.4
39.2
2160
15965
A03FA02
ATC
cisapride; oral, rectal
1.8
39.1
679
3774
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
2.1
39.1
485
2381
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.5
38.9
1342
9025
XG430
NOMESCO Finland
Spiroegometry
8.1
38.8
89
110
M01AX17
ATC
nimesulide; oral
1.4
38.8
2042
14969
R01BA01
ATC
phenylpropanolamine; oral
1.9
38.6
604
3242
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
38.4
4860
40711
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
38.4
1778
12720
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
4.8
38.1
130
270
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
38.1
5196
43926
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
38.0
5353
45438
G43.9
ICD-10 Finland
Migraine, unspecified
1.7
37.9
881
5357
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.7
37.8
808
4796
4224
FHL
Endonasal anthrostomy
3.9
37.7
158
401
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
37.7
2653
20431
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
37.5
7087
62282
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
37.1
813
4863
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
37.0
4401
36523
UJF32
NOMESCO Finland
Coloscopy
1.4
36.7
2201
16498
R83
ICPC
Respiratory infection other
1.3
36.7
3749
30482
J39.3
ICD-10 Finland
Upper respiratory tract hypersensitivity reaction, site unspecified
11.1
36.5
70
63
J04.0
ICD-10 Finland
Acute laryngitis
1.9
36.3
528
2758
J01.1
ICD-10 Finland
Acute frontal sinusitis
2.8
36.0
244
883
H03AA01
ATC
levothyroxine sodium; systemic
1.4
35.9
2368
18022
J05AB11
ATC
valaciclovir; oral
1.5
35.9
1368
9393
J33.9
ICD-10 Finland
Nasal polyp, unspecified
4.2
35.8
140
334
SPAT1252
SPAT
Overall medication plan or its review
1.9
35.7
523
2740
H66.9
ICD-10 Finland
Otitis media, unspecified
1.6
35.7
952
6006
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
2.7
35.7
248
913
N06AB10
ATC
escitalopram; oral
1.3
35.5
2635
20433
J01AA04
ATC
lymecycline; systemic
1.4
35.4
1772
12848
H10.4
ICD-10 Finland
Chronic conjunctivitis
4.1
35.3
143
353
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.5
35.3
1122
7399
SPAT1153
SPAT
Removal of sutures
1.3
35.2
2951
23305
A02BA04
ATC
nizatidine; systemic
1.8
35.2
591
3248
Z58.8
ICD-10 Finland
Other problems related to physical environment
13.5
34.9
61
45
N05CF01
ATC
zopiclone; oral
1.3
34.9
2859
22499
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
2.2
34.9
376
1739
SPAT1260
SPAT
Consultation of another employee
1.4
34.8
1845
13515
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
34.5
1665
11982
SPAT1301
SPAT
No procedures
1.3
34.1
3413
27619
J02AC02
ATC
itraconazole; systemic
1.4
33.9
1845
13576
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.6
33.9
925
5872
EMB10
NOMESCO Finland
Tonsillectomy
1.6
33.6
955
6120
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
33.6
792
4835
P01AB01
ATC
metronidazole; oral, rectal
1.3
33.5
4470
37511
XQ820
NOMESCO Finland
Exposure to medicinal substance
7.0
33.4
84
120
Z01.2
ICD-10 Finland
Dental examination
1.2
33.2
5493
47272
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
33.0
3935
32549
L23.5
ICD-10 Finland
Allergic contact dermatitis due to other chemical products
3.8
33.0
142
370
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.6
33.0
868
5458
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.2
32.8
346
1583
K30
ICD-10 Finland
Functional dyspepsia
1.5
32.8
1089
7245
L13
ICPC
Hip symptom/complaint
1.5
32.7
1263
8690
S87
ICPC
Dermatitis/atopic eczema
2.2
32.7
337
1526
E000004
ATC
NA
2.4
32.5
278
1151
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
32.5
6914
61158
A04
ICPC
Weakness/tiredness general
1.4
32.4
1442
10213
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
32.3
413
2054
W84
ICD-10 Finland
Unspecified threat to breathing
13.6
32.3
56
41
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.6
32.2
961
6234
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.5
32.2
1133
7639
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.2
32.1
323
1448
R03AK
ATC
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
6.1
32.1
89
146
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.2
32.0
320
1429
SPAT1312
SPAT
General health counselling
1.3
32.0
4116
34348
N06AB04
ATC
citalopram; systemic
1.4
31.9
2201
16841
N05BA04
ATC
oxazepam; oral
1.3
31.9
2592
20334
C09CA06
ATC
candesartan; oral
1.4
31.8
1917
14343
N05CF02
ATC
zolpidem; oral
1.4
31.8
1850
13760
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.0
31.8
422
2129
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
31.8
1324
9251
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.4
31.8
1444
10269
C05AA08
ATC
fluocortolone; rectal, topical
1.5
31.5
1300
9062
L17
ICPC
Foot/toe symptom/complaint
1.3
31.3
2596
20422
J01AA07
ATC
tetracycline; systemic
1.4
31.1
1927
14487
R07.0
ICD-10 Finland
Pain in throat
1.6
31.0
812
5098
7862A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Cough
5.9
30.5
87
148
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.6
30.1
848
5424
SPAT1216
SPAT
Assessment of functional ability
1.5
29.9
1094
7435
4222
FHL
Endonasal etmoidectomy
5.1
29.9
95
184
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.9
29.7
190
666
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
29.7
3764
31286
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.8
29.5
513
2852
T78.1
ICD-10 Finland
Other adverse food reactions, not elsewhere classified
25.5
29.5
41
16
C07AB07
ATC
bisoprolol; oral
1.3
29.4
3476
28638
SPAT1283
SPAT
Restricted health certificate
1.3
29.3
2997
24234
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
29.2
4815
41238
F51.0
ICD-10 Finland
Nonorganic insomnia
1.4
29.2
1599
11758
L30.1
ICD-10 Finland
Dyshidrosis [pompholyx]
4.8
29.1
99
207
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.4
29.0
1375
9848
A01AB04
ATC
amphotericin B; local oral
2.0
28.9
372
1857
SPAT1257
SPAT
Teaching of medicine inhalation technique
2.2
28.9
306
1406
N06AX16
ATC
venlafaxine; oral
1.4
28.9
1662
12326
L12
ICPC
Hand/finger symptom/complaint
1.4
28.7
1626
12023
D19
ICPC
Teeth/gum symptom/complaint
1.3
28.7
3301
27094
SPAT1359
SPAT
Use of symptom diary
2.3
28.6
267
1158
SPAT1254
SPAT
Administration of medicine
1.4
28.5
1525
11165
EMB30
NOMESCO Finland
Adenotomy
1.7
28.4
600
3550
R04
ICPC
Breathing problem other
2.1
28.3
345
1686
D07AC14
ATC
methylprednisolone aceponate; topical
1.8
28.3
491
2730
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
28.1
7329
65769
D06BX01
ATC
metronidazole; topical
1.5
28.1
1046
7133
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.7
27.6
572
3364
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
27.6
3627
30223
L02
ICPC
Back symptom/complaint
1.5
27.6
1065
7318
M01AX05
ATC
glucosamine; oral
1.4
27.5
1238
8773
N01
ICPC
Headache
1.4
27.5
1646
12281
UDC00
NOMESCO Finland
Ear microscopy
1.6
27.5
741
4683
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
27.5
7461
67160
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.5
27.2
1089
7539
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.9
27.0
387
2012
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
27.0
1330
9589
TQW80
NOMESCO Finland
Local dermatologic skincare
2.3
27.0
256
1119
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.4
26.9
1424
10399
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
26.8
2657
21365
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
26.8
1149
8068
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.5
26.7
825
5392
N06AB03
ATC
fluoxetine; oral
1.4
26.7
1354
9809
SPAT1311
SPAT
Counselling and guidance related to occupational health
1.9
26.7
409
2181
J35.2
ICD-10 Finland
Hypertrophy of adenoids
1.8
26.6
462
2568
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
2.2
26.5
279
1279
R51
ICD-10 Finland
Headache
1.6
26.5
658
4070
R00.2
ICD-10 Finland
Palpitations
1.6
26.5
764
4913
H10
ICD-10 Finland
Conjunctivitis
1.6
26.4
749
4795
DPA30
NOMESCO Finland
Sphenotomy
4.6
26.2
92
199
A06AC51
ATC
ispaghula, combinations; systemic
1.8
26.2
451
2504
J01EA01
ATC
trimethoprim; systemic
1.3
26.2
2586
20777
WX002
NOMESCO Finland
Sedation and analgesia
1.4
26.1
1680
12678
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
2.3
26.0
249
1094
4700A
ICD-9 Finland
Deflected nasal septum[DEFORMATIO SEPTI NASI]
3.4
25.9
129
381
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
25.8
1620
12179
R51.81
ICD-10 Finland
Facial pain NOS
2.3
25.7
252
1117
E66.01
ICD-10 Finland
Obesity due to excess calories
1.5
25.6
943
6414
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
2.9
25.5
159
549
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
1.8
25.5
476
2713
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
25.4
1065
7440
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.7
25.3
555
3316
S29
ICPC
Skin symptom/complaint other
1.4
25.2
1620
12217
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
25.1
1119
7909
H65.3
ICD-10 Finland
Chronic mucoid otitis media
1.9
25.1
395
2124
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
3.3
25.1
129
391
H92.0
ICD-10 Finland
Otalgia
1.6
25.1
622
3846
395
Kela drug reimbursment
Dupilumab
20.4
25.0
37
18
A98
ICPC
Health maint/preventive medicine
1.6
25.0
13786
133894
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
1.9
25.0
366
1919
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.7
24.9
564
3405
M02AA10
ATC
ketoprofen; topical
1.4
24.8
1369
10066
R07.3
ICD-10 Finland
Other chest pain
1.5
24.7
787
5178
ZX101
NOMESCO Finland
Sublingual
31.8
24.5
32
10
J47
ICD-10 Finland
Bronchiectasis
3.1
24.5
137
442
H02
ICPC
Hearing complaint
1.5
24.4
761
4984
M54.2
ICD-10 Finland
Cervicalgia
1.6
24.4
718
4636
J32
ICD-10 Finland
Chronic sinusitis
4.0
24.4
100
252
M01AH02
ATC
rofecoxib; oral
1.5
24.3
955
6584
SPAT1360
SPAT
Extensive global examination
1.6
24.2
656
4153
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
24.0
3617
30520
4239
FHL
Other measure in this category
5.5
23.8
71
129
J32.1
ICD-10 Finland
Chronic frontal sinusitis
4.9
23.8
79
162
M01AG02
ATC
tolfenamic acid; oral, rectal
1.3
23.8
1742
13403
Z57.3
ICD-10 Finland
Occupational exposure to other air contaminants
5.0
23.7
77
154
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
1.6
23.6
560
3420
Z01.7
ICD-10 Finland
Laboratory examination
1.4
23.6
1102
7859
P06
ICPC
Sleep disturbance
1.4
23.6
1095
7801
D09AB01
ATC
zinc bandage without supplements; topical
2.6
23.5
174
669
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.5
23.5
726
4745
X57
ICD-10 Finland
Unspecified privation
2.4
23.4
208
881
XQ830
NOMESCO Finland
Exposure to foodstuff
9.7
23.3
47
48
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
23.3
881
6028
SPAT1211
SPAT
Application of soft bandage
1.5
23.2
925
6394
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
2.1
23.2
270
1296
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.6
23.1
689
4470
XQ817
NOMESCO Finland
NA
11.9
23.1
42
35
M54.6
ICD-10 Finland
Pain in thoracic spine
1.5
23.0
733
4825
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.4
23.0
1298
9573
R35
ICD-10 Finland
Polyuria
1.7
22.9
451
2613
J31.1
ICD-10 Finland
Chronic nasopharyngitis
3.5
22.9
107
302
M48.0
ICD-10 Finland
Spinal stenosis
1.5
22.9
702
4580
A03CA02
ATC
clidinium and psycholeptics; oral
1.8
22.9
410
2307
L16
ICPC
Ankle symptom/complaint
1.4
22.8
1129
8140
J32.8
ICD-10 Finland
Other chronic sinusitis
5.4
22.8
69
128
D07AB01
ATC
clobetasone; topical
1.9
22.7
327
1706
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.4
22.7
1130
8154
R13
ICD-10 Finland
Dysphagia
1.7
22.7
481
2848
C07AA05
ATC
propranolol; systemic
1.3
22.6
2194
17548
F03
ICPC
Eye discharge
1.5
22.5
689
4493
R20.2
ICD-10 Finland
Paraesthesia of skin
1.5
22.5
693
4525
L11
ICPC
Wrist symptom/complaint
1.4
22.5
943
6587
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
3.0
22.4
133
447
R01AD04
ATC
flunisolide; nasal
3.8
22.4
96
252
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.2
22.3
4151
35753
N05AH04
ATC
quetiapine; oral
1.3
22.2
1939
15283
A03
ICPC
Fever
1.3
22.1
2232
17932
XG488
NOMESCO Finland
Other provokation of respiratroy tract
10.4
22.1
43
41
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.5
22.0
721
4775
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
22.0
1864
14632
UKC02
NOMESCO Finland
Cystoscopy
1.4
21.9
968
6827
R52.9
ICD-10 Finland
Pain, unspecified
1.5
21.9
805
5468
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.7
21.9
506
3070
WZA90
NOMESCO Finland
Other doctors statement
1.2
21.9
2769
22867
WX408
NOMESCO Finland
General anesthesy, balanced
1.2
21.7
2732
22545
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.2
21.7
4315
37382
D07XB05
ATC
dexamethasone, combinations; topical
2.1
21.6
261
1273
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.4
21.6
1221
9008
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.5
21.5
879
6107
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
3.9
21.4
88
223
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.5
21.3
649
4229
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.4
21.2
911
6392
F29
ICPC
Eye symptom/complaint other
1.5
21.0
828
5709
SBB10
NOMESCO Finland
Teeth copy
1.4
20.9
961
6831
WX110
NOMESCO Finland
Local anesthesy
1.2
20.9
9083
84301
M54
ICD-10 Finland
Dorsalgia
1.4
20.9
1202
8894
L24.0
ICD-10 Finland
Irritant contact dermatitis due to detergents
4.4
20.9
75
168
R60.0
ICD-10 Finland
Localized oedema
1.5
20.8
765
5197
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
2.6
20.8
154
594
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.2
20.8
3361
28489
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.4
20.7
1073
7794
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.5
20.7
719
4826
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
1.5
20.7
732
4932
R50.9
ICD-10 Finland
Fever, unspecified
1.3
20.7
1422
10824
XG432
NOMESCO Finland
Cold exponation and spirometry
9.5
20.6
42
44
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
4.4
20.6
74
166
XKD00
NOMESCO Finland
Uroflowmetry
1.5
20.4
798
5492
50709
ICD-8 Finland
Hay fever, Unspecified
4.0
20.4
83
209
R03BA07
ATC
mometasone; inhalant
3.1
20.2
114
372
R06.4
ICD-10 Finland
Hyperventilation
2.2
20.1
203
917
R06AX25
ATC
mizolastine; oral
5.5
20.1
59
106
L23.1
ICD-10 Finland
Allergic contact dermatitis due to adhesives
4.4
20.0
72
162
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.8
19.9
352
1975
H53.1
ICD-10 Finland
Subjective visual disturbances
1.6
19.9
562
3599
N17
ICPC
Vertigo/dizziness
1.4
19.8
919
6540
D11AH05
ATC
dupilumab; topical
20.6
19.8
29
14
R08
ICPC
Nose symptom/complaint other
1.8
19.8
366
2084
S06.0
ICD-10 Finland
Concussion
1.4
19.8
1085
7958
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
2.9
19.7
120
410
R52.2
ICD-10 Finland
Other chronic pain
1.8
19.6
317
1727
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.6
19.6
535
3396
G50.1
ICD-10 Finland
Atypical facial pain
2.3
19.5
180
779
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.5
19.5
692
4668
A01
ICPC
Pain general/multiple sites
1.5
19.5
680
4569
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
1.6
19.4
494
3078
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.6
19.4
471
2897
4711A
ICD-9 Finland
Nasal polyps, Polypoid sinus degeneration
6.5
19.4
50
76
L28
ICPC
Limited function/disability (L)
1.4
19.4
1030
7514
Z2221
NOMESCO Finland
Medical doctor
1.2
19.4
3013
25406
GD1AA
SPAT
NA
1.5
19.3
788
5469
R12
ICD-10 Finland
Heartburn
1.5
19.3
682
4597
F41.1
ICD-10 Finland
Generalized anxiety disorder
1.5
19.2
659
4412
R4110
NOMESCO Finland
Physiotherapy
1.2
19.2
2465
20354
N02CC03
ATC
zolmitriptan; nasal, oral
1.5
19.2
647
4317
N06AB06
ATC
sertraline; oral
1.3
19.2
1271
9614
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
2.5
19.1
153
616
SFA00
NOMESCO Finland
Small filling
1.3
19.0
1343
10256
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
19.0
1109
8220
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
1.6
19.0
497
3120
SDA02
NOMESCO Finland
Parodonthologic therapy
1.2
18.9
3876
33571
4211
FHL
Transeptal septal resection and reconstruction
3.4
18.9
91
265
C08DA01
ATC
verapamil; systemic
1.9
18.8
287
1529
A02BX02
ATC
sucralfate; oral
1.9
18.8
275
1446
KMAK
NOMESCO Finland
NA
1.2
18.8
6626
60149
M77.1
ICD-10 Finland
Lateral epicondylitis
1.4
18.7
780
5438
H29
ICPC
Ear symptom/complaint other
1.4
18.6
868
6185
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
2.3
18.6
172
747
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
18.6
1053
7762
G43
ICD-10 Finland
Migraine
1.5
18.5
651
4382
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
1.4
18.5
884
6325
344
Kela drug reimbursment
Omalizumab
9.7
18.4
37
38
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.4
18.4
926
6688
G04CA02
ATC
tamsulosin; oral
1.4
18.4
930
6725
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
18.4
1110
8270
H01.0
ICD-10 Finland
Blepharitis
1.5
18.4
567
3709
ZX112
NOMESCO Finland
Subcutaneous
2.2
18.3
181
812
A12
ICPC
ALLERGY/ALLERGIC REACTION
4.2
18.2
69
164
N04BC05
ATC
pramipexole; oral
1.6
18.0
509
3256
N02CC04
ATC
rizatriptan; oral
1.5
18.0
705
4857
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
3.7
18.0
79
214
R05CA10
ATC
expectorants - combinations
2.1
17.9
195
911
S01AD03
ATC
aciclovir; ophthalmic
1.8
17.9
325
1837
M54.1
ICD-10 Finland
Radiculopathy
1.8
17.9
336
1920
4221
FHL
Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room
2.9
17.9
109
374
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.3
17.9
1328
10216
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
4.4
17.8
64
144
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
2.1
17.8
199
941
DFF00
NOMESCO Finland
Pure tone audiometry
1.5
17.8
649
4402
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.5
17.6
624
4208
M50.3
ICD-10 Finland
Other cervical disc degeneration
2.1
17.6
196
927
A03FA01
ATC
metoclopramide; systemic, rectal
1.3
17.6
1874
15125
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.3
17.5
1163
8796
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.5
17.4
655
4475
G43.3
ICD-10 Finland
Complicated migraine
2.0
17.4
220
1097
D01
ICPC
Abdominal pain/cramps general
1.3
17.3
1290
9923
N06AX12
ATC
bupropion; oral
1.4
17.3
796
5658
J01MA06
ATC
norfloxacin; oral
1.3
17.3
1156
8753
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.4
17.3
823
5888
ZXD20
NOMESCO Finland
Day surgery
1.3
17.3
1264
9698
N05BA12
ATC
alprazolam; oral
1.4
17.2
913
6655
WX290
NOMESCO Finland
Other blockade of nerve
1.2
17.2
6135
55587
3028
Kela drug reimbursment
Mepolizumab
20.7
17.2
25
12
K08.80
ICD-10 Finland
Toothache NOS
1.4
17.2
905
6591
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.4
17.2
973
7176
D06BB03
ATC
aciclovir; topical
1.6
17.2
457
2886
SPAT1229
SPAT
Assessment of need for aid
1.6
17.1
493
3172
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.5
17.1
595
3999
RF410
NOMESCO Finland
NA
2.6
17.1
126
487
H10.5
ICD-10 Finland
Blepharoconjunctivitis
2.1
17.0
184
860
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.4
17.0
860
6219
H60.8
ICD-10 Finland
Other otitis externa
1.8
17.0
274
1493
XG466
NOMESCO Finland
Sleep oxymetry
1.9
17.0
246
1292
4226
FHL
Posterior radical surgery and possible etmoidectomy
3.8
17.0
71
185
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.1
16.9
181
843
E66.8
ICD-10 Finland
Other obesity
1.5
16.9
554
3677
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
1.6
16.8
486
3130
SPAT1097
SPAT
Recording of ECG
1.4
16.8
1033
7719
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.6
16.8
120
455
N03AE01
ATC
clonazepam; systemic
1.6
16.8
493
3188
J35.1
ICD-10 Finland
Hypertrophy of tonsils
1.8
16.8
293
1642
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.3
16.7
147
625
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
1.6
16.7
464
2959
WQ007
NOMESCO Finland
NA
7.1
16.6
40
56
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.6
16.6
412
2557
D82
ICPC
Teeth/gum disease
1.2
16.5
4452
39394
J21.90
ICD-10 Finland
Acute obstructive bronchitis in children
3.4
16.5
79
230
E0001A1
ATC
NA
1.8
16.5
296
1672
N05BA01
ATC
diazepam; systemic, rectal
1.3
16.5
1144
8711
DM1QA
SPAT
NA
1.9
16.4
259
1400
M35.7
ICD-10 Finland
Hypermobility syndrome
2.1
16.4
191
920
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.5
16.4
657
4546
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.4
16.4
909
6680
K59.1
ICD-10 Finland
Functional diarrhoea
1.6
16.3
438
2770
297
Kela drug reimbursment
NA
19.9
16.3
24
12
N39.3
ICD-10 Finland
Stress incontinence
1.5
16.3
581
3924
Z50.1
ICD-10 Finland
Other physical therapy
1.6
16.3
422
2645
R00.0
ICD-10 Finland
Tachycardia, unspecified
1.6
16.3
389
2387
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
16.3
12045
115508
A06AD11
ATC
lactulose; oral
1.4
16.2
883
6465
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.4
16.2
693
4855
XF402
NOMESCO Finland
ECG with work load test
1.4
16.1
715
5049
R1250
NOMESCO Finland
Evaluation of functional capability
2.0
16.0
209
1057
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
2.8
16.0
103
367
WX722
NOMESCO Finland
PEEP
1.7
16.0
323
1891
L50.1
ICD-10 Finland
Idiopathic urticaria
3.1
15.9
87
280
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.5
15.9
545
3649
Z57.2
ICD-10 Finland
Occupational exposure to dust
6.2
15.9
42
67
XG413
NOMESCO Finland
Spirometry with oscillometry
5.0
15.8
50
99
G54.0
ICD-10 Finland
Brachial plexus disorders
1.8
15.8
273
1520
S06
ICPC
Rash localized
1.5
15.8
490
3209
R03CC03
ATC
terbutaline; systemic
1.7
15.8
354
2137
SPAT1131
SPAT
Colonoscopy
1.9
15.7
247
1333
H93.1
ICD-10 Finland
Tinnitus
1.5
15.7
528
3525
ZXD10
NOMESCO Finland
Scheduled procedure
1.2
15.7
3794
33241
N06AX26
ATC
vortioxetine; oral
1.4
15.6
664
4650
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.6
15.6
418
2644
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
8.2
15.6
34
41
K05
ICPC
Irregular heartbeat other
2.0
15.6
201
1013
AA40B
NOMESCO Finland
NA
4.3
15.6
57
132
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.4
15.5
812
5910
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
1.9
15.5
231
1226
SPAT1043
SPAT
Audiometry
1.4
15.4
670
4710
R03DX09
ATC
mepolizumab; parenteral
21.9
15.4
22
10
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.2
15.4
2631
22323
K02.1
ICD-10 Finland
Caries of dentine
1.2
15.4
7585
70184
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.5
15.3
483
3177
DHB40
NOMESCO Finland
Conchotomy
6.3
15.3
40
63
D07CB01
ATC
triamcinolone and antibiotics; topical
2.0
15.3
192
955
XQ818
NOMESCO Finland
Conjunctival allergen provocation test
8.4
15.3
33
39
3DX05
NOMESCO Finland
NA
37.8
15.3
19
5
W22
ICD-10 Finland
Striking against or struck by other object(s)
1.4
15.3
679
4795
S88
ICPC
Dermatitis contact/allergic
1.9
15.2
211
1091
UJD02
NOMESCO Finland
Gastroscopy
1.7
15.2
347
2103
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
15.2
557
3784
N06AB05
ATC
paroxetine; oral
1.5
15.1
608
4210
D11
ICPC
Diarrhoea
1.3
15.1
1342
10575
G01AF05
ATC
econazole; vaginal
1.4
15.1
803
5858
C10AA07
ATC
rosuvastatin; oral
1.3
15.1
1583
12742
K04
ICPC
Palpitations/awareness of heart
1.5
15.1
448
2909
F32.1
ICD-10 Finland
Moderate depressive episode
1.4
15.1
705
5028
0
FHL
NA
8.6
15.1
32
37
R03DX05
ATC
omalizumab; parenteral
9.1
15.0
31
34
SPAT1240
SPAT
Therapeutic discussion
1.3
15.0
1457
11614
J01MA01
ATC
ofloxacin; systemic
1.5
15.0
583
4015
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.4
14.9
891
6628
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.1
14.9
166
787
K80
ICPC
Cardiac arrhythmia NOS
1.5
14.9
530
3579
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.0
14.8
195
989
G01AF04
ATC
miconazole; vaginal
1.5
14.8
477
3154
L20
ICPC
Joint symptom/complaint NOS
1.7
14.8
324
1943
L86
ICPC
Back syndrome with radiating pain
1.5
14.8
472
3114
R05DA01
ATC
ethylmorphine; oral
1.4
14.8
694
4952
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
1.9
14.7
221
1175
N03AX11
ATC
topiramate; oral
1.7
14.7
304
1794
N06AA12
ATC
doxepin; systemic
1.6
14.6
367
2283
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.5
14.6
495
3312
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
14.6
1491
11961
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.5
14.6
465
3070
M01AB55
ATC
diclofenac, combinations; oral
1.5
14.5
437
2843
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.5
14.5
583
4040
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
1.6
14.5
343
2102
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
1.5
14.5
522
3537
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.4
14.5
690
4937
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.5
14.5
526
3573
A07EB01
ATC
cromoglicic acid; oral
11.7
14.4
26
22
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.5
14.4
484
3232
R04.0
ICD-10 Finland
Epistaxis
1.5
14.4
438
2860
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
1.7
14.3
283
1646
J01DC04
ATC
cefaclor; oral
2.1
14.3
162
775
J06
ICD-10 Finland
Acute upper respiratory infections of multiple and unspecified sites
1.6
14.3
399
2552
HMAK
NOMESCO Finland
NA
1.3
14.3
1363
10839
M01AX01
ATC
nabumetone; oral
1.7
14.2
313
1880
-1
NOMESCO Finland
NA
1.2
14.2
4500
40223
P03
ICPC
Feeling depressed
1.3
14.2
1274
10053
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.5
14.1
535
3664
ACC51
NOMESCO Finland
Release of median nerve
1.4
14.1
617
4347
J39.9
ICD-10 Finland
Disease of upper respiratory tract, unspecified
2.9
14.1
83
282
S82
ICPC
Naevus/mole
1.3
14.1
1196
9367
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.2
14.1
4220
37549
SPAT1104
SPAT
Monitoring of emergency patient
1.5
14.0
515
3503
A44
ICPC
General and Unspecified, Preventive immunization/medic
1.4
14.0
655
4671
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.4
14.0
778
5714
N06AG02
ATC
moclobemide; oral
1.6
14.0
348
2161
XF404
NOMESCO Finland
Ambulatory ECG
1.4
14.0
645
4588
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
1.9
14.0
205
1082
B37.0
ICD-10 Finland
Candidal stomatitis
2.6
14.0
104
406
L60.0
ICD-10 Finland
Ingrowing nail
1.6
14.0
405
2614
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
1.5
13.9
537
3691
4451
FHL
Guitar cutting
1.5
13.9
490
3302
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.6
13.9
380
2416
R49.0
ICD-10 Finland
Dysphonia
2.1
13.9
151
708
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
1.6
13.9
330
2025
G04BD12
ATC
mirabegron; oral
1.4
13.9
583
4077
M24.2
ICD-10 Finland
Disorder of ligament
2.0
13.9
165
804
M01AC01
ATC
piroxicam; systemic, rectal
1.3
13.9
958
7289
50499
ICD-8 Finland
Deflected nasal septum
2.8
13.8
90
324
RF420
NOMESCO Finland
NA
2.2
13.8
133
594
J01.4
ICD-10 Finland
Acute pansinusitis
2.7
13.8
94
349
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
2.2
13.7
141
648
H65.2
ICD-10 Finland
Chronic serous otitis media
2.2
13.7
132
586
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
3.7
13.7
58
154
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.4
13.7
555
3851
H02AB09
ATC
hydrocortisone; systemic
1.8
13.7
239
1339
J05AH02
ATC
oseltamivir; oral
2.7
13.7
91
334
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.5
13.7
519
3554
DMB10
NOMESCO Finland
Radical maxillary antrotomy
3.9
13.7
55
140
E66.9
ICD-10 Finland
Obesity, unspecified
1.6
13.6
344
2146
A01AB10
ATC
natamycin; local oral
1.7
13.6
278
1637
L30.3
ICD-10 Finland
Infective dermatitis
1.7
13.6
278
1640
K03.80
ICD-10 Finland
Irradiated enamel
1.5
13.6
494
3355
A07DA03
ATC
loperamide; oral
1.8
13.5
243
1380
J01DB05
ATC
cefadroxil; oral
1.5
13.4
424
2791
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
1.9
13.4
188
979
K07.61
ICD-10 Finland
Cracking jaw joint
1.8
13.4
231
1291
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.5
13.4
501
3423
H57.1
ICD-10 Finland
Ocular pain
1.6
13.4
325
2010
R60.9
ICD-10 Finland
Oedema, unspecified
1.6
13.4
320
1971
ZXA00
NOMESCO Finland
Right side
1.2
13.4
2117
17805
7942A
ICD-9 Finland
Nonspecific abnormal results of function studies, Pulmonary
16.1
13.4
21
13
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
1.4
13.3
711
5189
D10AX03
ATC
azelaic acid; topical
1.3
13.3
1026
7927
XA402
NOMESCO Finland
ENMG
1.8
13.3
230
1286
K03.00
ICD-10 Finland
Approximal wear
1.5
13.3
498
3401
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.5
13.3
457
3068
6918C
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DIATHESIS (CONSTITUTIO) ATOPICA]
7.6
13.2
30
39
N03AX09
ATC
lamotrigine; oral
1.4
13.2
553
3863
B02AA02
ATC
tranexamic acid; systemic
1.2
13.2
1539
12533
G56.2
ICD-10 Finland
Lesion of ulnar nerve
1.7
13.2
272
1607
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
3.5
13.2
60
170
F32
ICD-10 Finland
Depressive episode
1.4
13.1
617
4408
F02
ICPC
Red eye
1.5
13.1
396
2581
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.3
13.1
861
6500
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.2
13.1
1974
16524
J02AB02
ATC
ketoconazole; oral
1.7
13.0
276
1642
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.5
13.0
433
2886
DPW99
NOMESCO Finland
Other operation on frontal or sphenoidal sinus
6.0
13.0
35
58
K59.0
ICD-10 Finland
Constipation
1.5
13.0
407
2675
S60.0
ICD-10 Finland
Contusion of finger(s) without damage to nail
1.6
13.0
364
2333
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
2.1
13.0
137
636
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
1.9
13.0
200
1076
DMW00
NOMESCO Finland
Intubation of maxillary antrum
4.5
12.9
45
100
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.4
12.9
518
3590
M22.4
ICD-10 Finland
Chondromalacia patellae
1.6
12.9
352
2241
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
2.4
12.9
104
426
J00
ICD-10 Finland
Acute nasopharyngitis [common cold]
1.7
12.9
259
1519
N06BA04
ATC
methylphenidate; oral
1.6
12.9
339
2139
S80.0
ICD-10 Finland
Contusion of knee
1.4
12.9
672
4891
J01CE02
ATC
phenoxymethylpenicillin; oral
1.1
12.8
9124
86040
DHA10
NOMESCO Finland
Biopsy of cavity of nose
2.9
12.8
76
261
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.4
12.8
688
5029
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
1.5
12.8
483
3310
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.4
12.8
593
4228
R03BB02
ATC
oxitropium bromide; inhalant
5.1
12.7
39
76
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.0
12.7
167
849
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
4.8
12.6
41
85
R55
ICD-10 Finland
Syncope and collapse
1.4
12.6
723
5341
D06
ICPC
Abdominal pain localized other
1.3
12.6
832
6290
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
1.3
12.6
1217
9690
L14
ICPC
Leg/thigh symptom/complaint
1.4
12.6
591
4220
505
Kela drug reimbursment
Allergy to cow's milk in infants
5.2
12.5
38
73
L23.6
ICD-10 Finland
Allergic contact dermatitis due to food in contact with skin
6.7
12.5
31
46
L04
ICPC
Chest symptom/complaint
1.4
12.5
514
3576
A02BA03
ATC
famotidine; systemic
1.8
12.5
229
1306
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.5
12.5
488
3366
M01AB08
ATC
etodolac; oral
1.4
12.5
583
4163
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.4
12.3
640
4652
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.3
12.3
877
6698
WIX00
NOMESCO Finland
Allergy cleanup guidance
6.2
12.3
32
51
L10
ICPC
Elbow symptom/complaint
1.5
12.3
433
2923
UJF92
NOMESCO Finland
Capsular endoscopy
1.8
12.3
212
1189
A99
ICPC
Disease/condition unspecnature/site
1.4
12.3
632
4589
Z2445
NOMESCO Finland
Psychologist
1.4
12.3
523
3668
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
5.5
12.2
35
63
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.4
12.2
677
4976
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
1.8
12.2
190
1031
S02CA02
ATC
flumetasone and antiinfectives; otic
1.5
12.1
457
3127
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
5.1
12.1
37
72
R49.09
ICD-10 Finland
Unspecified dysphonia
2.5
12.1
89
348
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.2
12.1
2715
23554
J39.8
ICD-10 Finland
Other specified diseases of upper respiratory tract
3.5
12.0
54
152
N05AB04
ATC
prochlorperazine; systemic, rectal
2.0
12.0
147
730
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.4
12.0
689
5094
Z50.5
ICD-10 Finland
Speech therapy
2.0
11.9
148
736
WW200
NOMESCO Finland
Immunization
1.7
11.9
255
1526
R11
ICD-10 Finland
Nausea and vomiting
1.3
11.9
751
5636
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.4
11.9
629
4591
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.3
11.9
731
5466
M77.4
ICD-10 Finland
Metatarsalgia
1.4
11.9
505
3540
R39.1
ICD-10 Finland
Other difficulties with micturition
1.9
11.9
183
987
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.4
11.8
647
4748
ZXA05
NOMESCO Finland
Left side
1.2
11.8
1946
16425
D02
ICPC
Abdominal pain epigastric
1.4
11.8
544
3875
M54.3
ICD-10 Finland
Sciatica
1.5
11.7
458
3161
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.3
11.7
765
5772
F34.1
ICD-10 Finland
Dysthymia
1.5
11.7
363
2383
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.4
11.7
699
5202
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.6
11.7
261
1582
4720C
ICD-9 Finland
Chronic pharyngitis and nasopharyngitis, Chronic rhinitis[RHINITIS VASOMOTORICA]
10.4
11.7
22
21
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.3
11.6
806
6135
G04CA01
ATC
alfuzosin; oral
1.4
11.6
499
3506
ZY010
NOMESCO Finland
Hospital outpatient
1.4
11.6
606
4408
4740A
ICD-9 Finland
Chronic disease of tonsils and adenoids, Chronic tonsillitis
1.6
11.6
322
2062
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.2
11.6
1447
11869
XG460
NOMESCO Finland
Short time oxymetry
2.3
11.6
101
432
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.4
11.5
488
3421
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.2
11.5
2354
20249
XG405
SPAT
NA
3.2
11.5
58
179
N06AA10
ATC
nortriptyline; systemic
1.8
11.5
192
1067
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
11.5
1200
9643
J38.2
ICD-10 Finland
Nodules of vocal cords
2.7
11.5
74
269
G47.9
ICD-10 Finland
Sleep disorder, unspecified
1.8
11.5
208
1184
S21
ICPC
Skin texture symptom/complaint
1.3
11.5
1056
8357
D07XC01
ATC
betamethasone, combinations; topical
1.3
11.5
947
7389
6931A
ICD-9 Finland
Dermatitis due to substances taken internally, Due to food
11.0
11.4
21
19
SPAT1281
SPAT
Other administrative function
1.3
11.4
756
5713
N76.0
ICD-10 Finland
Acute vaginitis
1.3
11.4
753
5691
WQ000
SPAT
NA
119.2
11.4
12
*
4939B
ICD-9 Finland
Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]
6.1
11.4
30
49
C05AA01
ATC
hydrocortisone; rectal, topical
1.5
11.4
350
2297
N06AX22
ATC
agomelatine; oral
1.7
11.4
237
1406
S22.3
ICD-10 Finland
Fracture of rib
1.5
11.3
430
2951
A05
ICPC
Feeling ill
1.3
11.3
866
6685
Z01.9
ICD-10 Finland
Special examination, unspecified
1.5
11.3
429
2945
N89
ICPC
Migraine
1.4
11.3
453
3144
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.5
11.3
440
3035
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.3
11.2
1188
9558
N94.6
ICD-10 Finland
Dysmenorrhoea, unspecified
1.7
11.2
246
1481
H02BX01
ATC
methylprednisolone, combinations; systemic
1.6
11.2
292
1840
J38.3
ICD-10 Finland
Other diseases of vocal cords
2.4
11.2
90
370
M54.8
ICD-10 Finland
Other dorsalgia
1.5
11.2
357
2362
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
1.5
11.2
378
2533
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.3
11.1
953
7470
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.4
11.1
475
3340
XJH00
NOMESCO Finland
Transanal ultrasonography
1.7
11.1
240
1443
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
3.6
11.1
49
137
SPAT1081
SPAT
Cardiorespiratory global assessment
1.5
11.1
325
2109
G50.0
ICD-10 Finland
Trigeminal neuralgia
2.0
11.0
135
671
R23.3
ICD-10 Finland
Spontaneous ecchymoses
2.0
11.0
142
721
ZXE10
NOMESCO Finland
More than one and less than three hours
1.2
11.0
3394
30150
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
1.8
11.0
176
965
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
1.5
11.0
383
2584
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.4
11.0
519
3717
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.4
11.0
512
3657
49099
ICD-8 Finland
Bronchitis, unspecified
2.4
10.9
92
388
N06AX05
ATC
trazodone; oral
1.7
10.9
235
1411
N02CC05
ATC
almotriptan; oral
1.4
10.9
460
3225
X15
ICPC
Vaginal symptom/complaint other
1.5
10.9
420
2892
U02
ICPC
Urinary frequency/urgency
1.3
10.9
1181
9529
J33.1
ICD-10 Finland
Polypoid sinus degeneration
9.1
10.9
22
24
R05CB02
ATC
bromhexine; systemic
2.3
10.9
99
431
D01AA02
ATC
natamycin; topical
1.8
10.9
194
1101
L50.2
ICD-10 Finland
Urticaria due to cold and heat
3.5
10.9
49
139
R23
ICPC
Voice symptom/complaint
1.7
10.9
215
1256
C03CA01
ATC
furosemide; systemic
1.2
10.9
1339
10961
G01AA10
ATC
clindamycin; vaginal
1.2
10.8
1610
13442
4900A
ICD-9 Finland
Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]
3.9
10.8
43
110
RF120
NOMESCO Finland
NA
2.2
10.8
109
499
U01
ICPC
Dysuria/painful urination
1.3
10.7
719
5447
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
1.5
10.7
306
1975
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.4
10.7
618
4575
K90.0
ICD-10 Finland
Coeliac disease
1.6
10.7
271
1699
ZYC01
NOMESCO Finland
Remote contact by phone
1.4
10.7
450
3152
K11.2
ICD-10 Finland
Sialoadenitis
1.6
10.7
270
1690
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
1.9
10.7
149
779
J31.2
ICD-10 Finland
Chronic pharyngitis
2.5
10.6
80
318
N02CC02
ATC
naratriptan; oral
1.8
10.6
186
1049
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.3
10.6
938
7383
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
10.6
1144
9226
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.5
10.6
312
2028
B02.9
ICD-10 Finland
Zoster without complication
1.5
10.6
351
2341
S90.3
ICD-10 Finland
Contusion of other and unspecified parts of foot
1.6
10.6
258
1603
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
10.6
673
5063
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
1.5
10.5
319
2089
H13
ICPC
Plugged feeling ear
1.2
10.5
1279
10456
N02CC07
ATC
frovatriptan; oral
1.4
10.5
503
3610
S01KA02
ATC
hypromellose; ophthalmic
2.1
10.5
117
560
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
2.1
10.5
117
560
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
2.5
10.5
82
333
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.4
10.5
508
3655
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.4
10.5
516
3721
S89.9
ICD-10 Finland
Unspecified injury of lower leg
1.5
10.4
333
2203
1210
FHL
Anthroscopy
3.8
10.4
42
109
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.5
10.4
316
2070
RD210
NOMESCO Finland
NA
1.7
10.4
209
1231
L29
ICPC
Musculoskeletal sympt/complt other
1.4
10.4
610
4529
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
1.8
10.4
176
981
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.5
10.4
361
2436
M25.2
ICD-10 Finland
Flail joint
2.0
10.3
136
695
F90.0
ICD-10 Finland
Disturbance of activity and attention
1.4
10.3
411
2848
S63.5
ICD-10 Finland
Sprain and strain of wrist
1.5
10.3
363
2451
M23.8
ICD-10 Finland
Other internal derangements of knee
1.5
10.3
347
2325
F71
ICPC
Conjunctivitis allergic
3.3
10.3
51
156
DGW00
NOMESCO Finland
Dilatation of eustachian tube
4.4
10.3
36
82
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.2
10.2
2775
24401
Z73.0
ICD-10 Finland
Burn-out
1.5
10.2
341
2277
RJ410
NOMESCO Finland
NA
3.4
10.2
47
136
ZXE00
NOMESCO Finland
One hour or less
1.1
10.2
4238
38385
P76
ICPC
Depressive disorder
1.3
10.2
740
5672
G04BD04
ATC
oxybutynin; oral, transdermal
1.5
10.2
336
2241
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.4
10.2
517
3747
XCK00
NOMESCO Finland
Perimetry
1.4
10.2
437
3074
J31
ICD-10 Finland
Chronic rhinitis, nasopharyngitis and pharyngitis
2.2
10.2
100
455
M47.9
ICD-10 Finland
Spondylosis, unspecified
1.7
10.1
198
1158
I10
ICD-10 Finland
Essential (primary) hypertension
1.1
10.1
3849
34663
D72.1
ICD-10 Finland
Eosinophilia
3.5
10.1
45
127
4719X
ICD-9 Finland
Nasal polyps, Unspecified nasal polyp
13.0
10.1
17
13
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.2
10.1
1078
8689
J33
ICD-10 Finland
Nasal polyp
2.9
10.0
59
203
X27
ICD-10 Finland
Contact with other specified venomous animals
7.8
10.0
22
28
1220
FHL
Arthroscopy
1.6
10.0
282
1815
G44.1
ICD-10 Finland
Vascular headache, not elsewhere classified
2.6
10.0
71
272
N07CA01
ATC
betahistine; oral
1.4
10.0
450
3197
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
1.5
10.0
291
1887
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
1.6
10.0
269
1712
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
1.4
10.0
409
2855
U09.9
ICD-10 Finland
Post COVID-19 condition, unspecified
2.3
10.0
90
392
M01AH03
ATC
valdecoxib; oral
1.4
10.0
466
3329
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.3
10.0
803
6245
D01AE15
ATC
terbinafine; topical
1.4
9.9
476
3420
L30.8
ICD-10 Finland
Other specified dermatitis
1.7
9.9
188
1089
4742A
ICD-9 Finland
Chronic disease of tonsils and adenoids, Adenoid vegetations
1.6
9.8
263
1672
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
1.6
9.8
222
1349
D03
ICPC
Heartburn
1.5
9.8
280
1807
K07.4
ICD-10 Finland
Malocclusion, unspecified
1.7
9.8
179
1026
R10.2
ICD-10 Finland
Pelvic and perineal pain
1.7
9.8
205
1221
S99.9
ICD-10 Finland
Unspecified injury of ankle and foot
1.6
9.8
230
1412
XX9CW
NOMESCO Finland
Submitting image material and/or investigation material to patient
2.4
9.8
78
321
ZXX05
NOMESCO Finland
Extent of procedure, 5 units
3.4
9.8
46
136
R78
ICPC
Acute bronchitis/bronchiolitis
1.7
9.8
180
1034
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
4.5
9.7
33
73
I45.9
ICD-10 Finland
Conduction disorder, unspecified
2.8
9.7
59
208
M13.9
ICD-10 Finland
Arthritis, unspecified
1.3
9.7
585
4361
AA1AD
NOMESCO Finland
CT of head and brain
1.2
9.7
1609
13567
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.2
9.7
1228
10080
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.5
9.7
348
2363
Z00.8
ICD-10 Finland
Other general examinations
1.3
9.7
695
5320
T63.4
ICD-10 Finland
Toxic effect: Venom of other arthropods
2.3
9.7
84
361
KHV
NOMESCO Finland
NA
2.5
9.7
71
280
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
1.7
9.7
179
1029
H60
ICD-10 Finland
Otitis externa
1.4
9.7
444
3166
M75
ICD-10 Finland
Shoulder lesions
1.5
9.7
328
2201
VALMI
NOMESCO Finland
NA
1.1
9.7
3211
28640
M67.4
ICD-10 Finland
Ganglion
1.3
9.7
597
4472
N02CC06
ATC
eletriptan; oral
1.4
9.6
396
2763
P01
ICPC
Feeling anxious/nervous/tense
1.2
9.6
1539
12936
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
1.3
9.6
599
4488
46699
ICD-8 Finland
Acute bronchitis and bronchiolitis
1.8
9.6
147
797
V01AA03
ATC
house dust mites
54.6
9.6
11
*
C07AB02
ATC
metoprolol; systemic
1.2
9.6
1159
9468
4741B
ICD-9 Finland
Chronic disease of tonsils and adenoids, Hypertrophy of tonsils and adenoids[HYPERTROPHIA TONSILLAE PHARYNGICAE]
1.7
9.6
203
1215
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
9.6
825
6474
M15
ICD-10 Finland
Polyarthrosis
1.6
9.6
249
1573
Y96.9
ICD-10 Finland
Unspecified type of accident
1.9
9.6
144
774
SPAT1268
SPAT
Allergy testing
3.5
9.6
43
123
N02AA05
ATC
oxycodone; systemic
1.3
9.5
810
6344
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
1.5
9.5
325
2186
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.3
9.5
786
6136
M01AG01
ATC
mefenamic acid; oral
1.6
9.5
227
1405
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.3
9.5
603
4535
V01AA11
ATC
animals
8.3
9.5
20
24
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
2.4
9.5
76
315
R49.1
ICD-10 Finland
Aphonia
3.6
9.4
41
114
Y0499
ICD-8 Finland
Investigation of respiratory system
2.7
9.4
64
240
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
1.5
9.4
338
2297
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
1.5
9.4
329
2228
T78.8
ICD-10 Finland
Other adverse effects, not elsewhere classified
29.8
9.4
12
*
K20
ICD-10 Finland
Oesophagitis
2.0
9.3
115
574
D01AC02
ATC
miconazole; topical
1.4
9.3
542
4022
F41.8
ICD-10 Finland
Other specified anxiety disorders
1.5
9.3
317
2132
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.3
9.3
683
5242
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
2.1
9.3
106
513
C08CA13
ATC
lercanidipine; oral
1.3
9.3
693
5330
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
1.8
9.3
150
827
M70.7
ICD-10 Finland
Other bursitis of hip
1.8
9.3
163
923
XG431
NOMESCO Finland
Oscillometric spirometry with exercise provocation
4.9
9.3
29
59
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
1.5
9.3
325
2195
S76
ICPC
Skin infection other
1.4
9.3
373
2594
C10AA03
ATC
pravastatin; oral
1.5
9.3
319
2147
N30
ICD-10 Finland
Cystitis
1.3
9.3
715
5527
D09
ICPC
Nausea
1.3
9.2
551
4105
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.4
9.2
503
3690
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.3
9.2
727
5637
L71.9
ICD-10 Finland
Rosacea, unspecified
1.7
9.2
184
1085
M77.9
ICD-10 Finland
Enthesopathy, unspecified
1.6
9.2
253
1622
90494
NOMESCO Finland
NA
8.6
9.2
19
22
R04.2
ICD-10 Finland
Haemoptysis
1.7
9.2
173
1002
C09CA01
ATC
losartan; oral
1.2
9.2
1515
12770
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
1.8
9.2
151
839
L07
ICPC
Jaw symptom/complaint
1.9
9.2
133
707
J03
ICD-10 Finland
Acute tonsillitis
1.5
9.2
316
2130
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.5
9.2
304
2031
R30.0
ICD-10 Finland
Dysuria
1.5
9.2
310
2081
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
2.3
9.2
79
338
SPAT1106
SPAT
Acupuncture
2.4
9.2
76
319
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.3
9.1
789
6197
H26.4
ICD-10 Finland
After-cataract
1.4
9.1
358
2479
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.3
9.1
712
5516
G04CB02
ATC
dutasteride; oral
1.7
9.1
181
1066
R05DB20
ATC
other cough suppressants - combinations
1.4
9.1
511
3771
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
1.6
9.1
237
1500
L01
ICD-10 Finland
Impetigo
1.8
9.1
155
870
U07
ICPC
Urine symptom/complaint other
1.4
9.0
402
2851
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
1.6
9.0
211
1300
S43.4
ICD-10 Finland
Sprain and strain of shoulder joint
1.5
9.0
295
1968
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.3
9.0
734
5718
F43.1
ICD-10 Finland
Post-traumatic stress disorder
1.5
9.0
301
2019
M03BB52
ATC
chlormezanone, combinations excl. psycholeptics; oral, rectal
1.9
9.0
129
682
L23
ICD-10 Finland
Allergic contact dermatitis
2.6
9.0
61
229
4732A
ICD-9 Finland
Chronic sinusitis, Ethmoidal
5.3
9.0
26
49
B00.10
ICD-10 Finland
Herpes simplex facialis
2.2
8.9
84
376
WZB00
SPAT
NA
1.3
8.9
755
5910
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
1.7
8.9
170
986
Z02.7
ICD-10 Finland
Issue of medical certificate
1.4
8.9
514
3810
R07.2
ICD-10 Finland
Precordial pain
1.9
8.9
131
702
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
2.3
8.9
77
329
C08DB01
ATC
diltiazem; oral
1.6
8.9
199
1209
T93.3
ICD-10 Finland
Sequelae of dislocation, sprain and strain of lower limb
2.2
8.9
89
411
K04.08
ICD-10 Finland
Other specified pulpit
1.3
8.9
739
5775
N03AF01
ATC
carbamazepine; oral, rectal
1.4
8.9
346
2395
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
2.4
8.9
69
282
K02.0
ICD-10 Finland
Caries limited to enamel
1.2
8.9
1864
16048
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.4
8.9
465
3394
G03DC02
ATC
norethisterone; oral
1.3
8.8
873
6968
C10AX09
ATC
ezetimibe; oral
1.3
8.8
587
4448
N94.4
ICD-10 Finland
Primary dysmenorrhoea
1.5
8.8
256
1663
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.3
8.8
638
4896
J35.3
ICD-10 Finland
Hypertrophy of tonsils with hypertrophy of adenoids
1.8
8.8
155
882
J38.4
ICD-10 Finland
Oedema of larynx
2.8
8.7
52
182
N05AH02
ATC
clozapine; systemic
0.5
8.7
69
1341
S01
ICPC
Pain/tenderness of skin
1.4
8.7
337
2329
N62
ICD-10 Finland
Hypertrophy of breast
1.4
8.7
382
2701
F60.5
ICD-10 Finland
Anankastic personality disorder
1.9
8.7
117
607
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
1.8
8.7
141
781
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
1.6
8.7
212
1320
U71
ICPC
Cystitis/urinary infection other
1.3
8.7
526
3927
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.4
8.7
401
2864
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
1.7
8.7
182
1089
DAX08
NOMESCO Finland
Fitting of hearing aid
1.7
8.7
168
983
R10.0
ICD-10 Finland
Acute abdomen
1.5
8.7
265
1743
K60.1
ICD-10 Finland
Chronic anal fissure
1.6
8.6
190
1152
T82
ICPC
Obesity
1.4
8.6
364
2559
P25
ICPC
Phase of life problem adult
1.4
8.6
452
3301
P02
ICPC
Acute stress reaction
1.3
8.6
521
3892
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
4.3
8.6
30
69
SXC05
NOMESCO Finland
Other oral or dental procedure
1.3
8.6
705
5501
J38.5
ICD-10 Finland
Laryngeal spasm
3.7
8.6
35
93
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.3
8.6
544
4092
K59.09
ICD-10 Finland
Constipation, unspecified
1.4
8.6
384
2726
1240
FHL
Bronchoscopy
2.7
8.6
56
208
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
1.5
8.6
294
1983
D10AF01
ATC
clindamycin; topical
1.3
8.6
532
3991
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
1.3
8.6
616
4722
7840A
ICD-9 Finland
Symptoms involving head and neck, Headache
2.2
8.5
78
345
L71.0
ICD-10 Finland
Perioral dermatitis
1.7
8.5
154
882
XQ809
NOMESCO Finland
NA
11.5
8.5
15
13
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.4
8.5
397
2843
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
1.8
8.5
141
788
104
Kela drug reimbursment
Thyroid insufficiency
1.3
8.5
515
3850
L01.1
ICD-10 Finland
Impetiginization of other dermatoses
2.5
8.5
62
244
S04
ICPC
Lump/swelling localized
1.3
8.5
857
6865
Y59
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances
2.1
8.5
86
400
N30.0
ICD-10 Finland
Acute cystitis
1.2
8.5
1243
10360
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.6
8.5
110
1868
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
1.5
8.5
258
1695
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
1.8
8.4
147
832
H53.2
ICD-10 Finland
Diplopia
1.6
8.4
207
1293
W19
ICD-10 Finland
Unspecified fall
1.3
8.4
774
6131
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
1.6
8.4
215
1357
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
1.2
8.3
1000
8163
R01
ICPC
Pain respiratory system
1.7
8.3
149
852
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
1.6
8.3
229
1469
A10BJ02
ATC
liraglutide; parenteral
1.7
8.3
154
888
WX400
NOMESCO Finland
Inhalation anesthesy
1.4
8.3
446
3271
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
2.6
8.3
57
216
JHB00
NOMESCO Finland
Hemorrhoidectomy
1.6
8.3
227
1456
F01
ICPC
Eye pain
1.5
8.3
261
1730
4452
FHL
Tonsil surgery
1.4
8.3
338
2358
N06AX03
ATC
mianserin; oral
1.4
8.3
331
2305
L82
ICD-10 Finland
Seborrhoeic keratosis
1.2
8.2
1012
8283
S92.5
ICD-10 Finland
Fracture of other toe
1.5
8.2
248
1626
M76.8
ICD-10 Finland
Other enthesopathies of lower limb, excluding foot
1.7
8.2
164
969
M05BA04
ATC
alendronic acid; oral
1.4
8.2
375
2674
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
1.7
8.2
174
1046
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
5.4
8.2
23
42
EMB20
NOMESCO Finland
Adenotonsillectomy
1.6
8.2
221
1411
S01CA03
ATC
hydrocortisone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.1
8.2
88
418
G93.3
ICD-10 Finland
Postviral fatigue syndrome
2.6
8.2
56
212
OAA65
SPAT
NA
1.2
8.2
1203
10031
L18
ICPC
Muscle pain
1.4
8.2
325
2260
H00.00
ICD-10 Finland
Hordeolum
1.4
8.2
370
2637
49308
ICD-8 Finland
Asthma, Alia definita
4.3
8.1
28
64
DM1AI
SPAT
NA
2.8
8.1
49
174
A97
ICPC
No disease
1.2
8.1
1496
12736
DFF15
NOMESCO Finland
Speech audiometry
1.6
8.1
217
1383
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.1
8.1
3191
28728
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
1.7
8.1
150
866
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
4.2
8.1
29
69
D01AC03
ATC
econazole; topical
1.4
8.1
417
3040
M03BX01
ATC
baclofen; systemic
1.8
8.1
135
754
R05CB01
ATC
acetylcysteine; inhalant, oral
2.1
8.1
85
401
L19
ICPC
Muscle symptom/complaint NOS
1.6
8.1
202
1267
P01BA02
ATC
hydroxychloroquine; oral
1.3
8.1
655
5107
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
1.5
8.1
282
1913
S83.2
ICD-10 Finland
Tear of meniscus, current
1.3
8.0
594
4571
M01AB01
ATC
indometacin; systemic, rectal
1.4
8.0
364
2591
I78.1
ICD-10 Finland
Naevus, non-neoplastic
1.6
8.0
182
1112
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
1.6
8.0
177
1074
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
0.4
8.0
39
893
X48
ICD-10 Finland
Accidental poisoning by and exposure to pesticides
11.6
8.0
14
12
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
1.9
8.0
103
527
I45.0
ICD-10 Finland
Right fascicular block
3.0
8.0
43
142
R2110
NOMESCO Finland
Giving the first information
1.3
8.0
661
5166
SPAT1285
SPAT
Provision of consultation response
1.4
8.0
414
3021
H81.3
ICD-10 Finland
Other peripheral vertigo
1.6
8.0
175
1064
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
1.7
7.9
156
919
L26
ICD-10 Finland
Exfoliative dermatitis
5.0
7.9
24
48
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
3.5
7.9
35
100
W79
ICD-10 Finland
Inhalation and ingestion of food causing obstruction of respiratory tract
5.5
7.9
22
40
N77.1*A60.0
ICD-10 Finland
Vaginitis, vulvitis and vulvovaginitis in herpesviral [herpes simplex] infection
2.4
7.9
60
244
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
1.8
7.9
122
666
C10AC01
ATC
colestyramine; oral
1.6
7.9
192
1200
C10AA05
ATC
atorvastatin; oral
1.1
7.8
2252
19856
K29.3
ICD-10 Finland
Chronic superficial gastritis
1.6
7.8
175
1070
G03DB01
ATC
dydrogesterone; oral
1.2
7.8
1417
12048
L71.8
ICD-10 Finland
Other rosacea
1.9
7.8
113
602
GD1AD
NOMESCO Finland
Thorax CT examination
1.5
7.8
244
1615
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
7.8
1149
9588
H10.2
ICD-10 Finland
Other acute conjunctivitis
1.8
7.8
123
678
M20.1
ICD-10 Finland
Hallux valgus (acquired)
1.3
7.8
562
4313
R5599
NOMESCO Finland
Other rehabilitation service
1.5
7.8
221
1434
S92.3
ICD-10 Finland
Fracture of metatarsal bone
1.4
7.7
321
2252
NHE15
NOMESCO Finland
Suture or reinsertion of ligament of ankle
2.0
7.7
92
457
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
1.7
7.7
150
880
RF211
NOMESCO Finland
NA
4.6
7.7
25
54
S15
ICPC
Foreign body in skin
1.3
7.7
455
3388
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.3
7.7
574
4425
H66
ICD-10 Finland
Suppurative and unspecified otitis media
1.5
7.7
270
1834
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.3
7.7
535
4085
TQC05
NOMESCO Finland
Puncture of skin of upper limb
4.8
7.7
24
50
N83.1
ICD-10 Finland
Corpus luteum cyst
1.7
7.7
139
800
G44.8
ICD-10 Finland
Other specified headache syndromes
1.8
7.7
116
628
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
1.5
7.7
226
1478
G44.0
ICD-10 Finland
Cluster headache syndrome
1.9
7.7
110
585
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.0
7.6
87
427
R68.2
ICD-10 Finland
Dry mouth, unspecified
2.6
7.6
51
194
ZXB87
NOMESCO Finland
Balloon dilation, paranasal sinuses
5.8
7.6
20
34
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
1.6
7.6
194
1225
R03
ICPC
Wheezing
2.0
7.6
89
441
D93
ICPC
Irritable bowel syndrome
1.8
7.6
116
633
F41.09
ICD-10 Finland
UNS Panic Syndrome
1.4
7.6
323
2279
J32.3
ICD-10 Finland
Chronic sphenoidal sinusitis
4.0
7.6
28
69
I84.5
ICD-10 Finland
External hemorrhoids without complication
1.5
7.6
225
1474
X01
ICPC
Genital pain female
1.9
7.6
108
576
6925B
ICD-9 Finland
Contact dermatitis and other eczema, Due to food in contact with skin[DERMATITIS ARTEFACTA EX ALIMENTIS ALLERGICA,VÄLITÖN]
18.2
7.6
11
6
50701
ICD-8 Finland
Hay fever, Vernalis
7.9
7.5
16
20
KCV04
NOMESCO Finland
Distension of bladder with fluid
2.2
7.5
71
320
U07.2
ICD-10 Finland
COVID-19, virus not identified
1.1
7.5
2434
21627
M75.8
ICD-10 Finland
Other shoulder lesions
1.4
7.5
292
2022
SAB02
NOMESCO Finland
Oral and dental health check by dental hygienist or dental assistant
1.2
7.5
1160
9718
S01XA18
ATC
ciclosporin; ophthalmic
2.7
7.5
49
183
M65.3
ICD-10 Finland
Trigger finger
1.4
7.5
306
2140
A32
ICPC
General and Unspecified, Sensitivity test
8.8
7.5
15
17
7869X
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Other symptoms involving respiratory system and chest[SYMPTOMA RESPIRATORIA ALIA DEFINITA]
9.9
7.5
14
14
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
1.6
7.5
160
968
G03CC04
ATC
estrone; systemic
1.8
7.5
122
678
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.2
7.5
995
8217
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.3
7.4
597
4648
M76.6
ICD-10 Finland
Achilles tendinitis
1.4
7.4
350
2511
R4190
NOMESCO Finland
Nutritional therapy
1.4
7.4
336
2393
J01.8
ICD-10 Finland
Other acute sinusitis
2.4
7.4
59
245
H02.3
ICD-10 Finland
Blepharochalasis
1.4
7.4
333
2371
N41.1
ICD-10 Finland
Chronic prostatitis
1.8
7.4
127
717
4660A
ICD-9 Finland
Acute bronchitis and bronchiolitis, Acute bronchitis
1.9
7.4
96
495
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.4
7.4
289
2006
G04BD08
ATC
solifenacin; oral
1.4
7.4
352
2535
M01AE52
ATC
naproxen and esomeprazole; oral
1.5
7.4
254
1718
RJ421
NOMESCO Finland
NA
3.2
7.4
36
112
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.4
7.4
335
2391
SPAT1284
SPAT
Extensive health certificate
1.4
7.3
287
1991
JG1JB
NOMESCO Finland
Defekography with X-ray
2.4
7.3
61
258
DHB45
NOMESCO Finland
Turbinate reduction
5.0
7.3
22
44
H53.9
ICD-10 Finland
Visual disturbance, unspecified
1.5
7.3
213
1389
K62.6
ICD-10 Finland
Ulcer of anus and rectum
2.1
7.3
73
339
K58
ICD-10 Finland
Irritable bowel syndrome
1.5
7.3
234
1558
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.2
7.3
981
8107
S01AA13
ATC
fusidic acid; ophthalmic
1.4
7.3
315
2227
H65.0
ICD-10 Finland
Acute serous otitis media
1.6
7.3
170
1052
J01CA02
ATC
pivampicillin; oral
1.4
7.3
316
2239
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
1.7
7.3
135
781
RP210
NOMESCO Finland
NA
3.7
7.2
29
77
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.9
7.2
2558
28039
XKC03
NOMESCO Finland
Water cystometry
1.5
7.2
201
1296
A08
ICPC
Swelling
1.5
7.2
236
1577
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
1.7
7.2
140
820
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
1.5
7.2
261
1784
UJH02
NOMESCO Finland
Anoscopy
1.4
7.2
295
2064
V07AB
ATC
Solvents and diluting agents, incl. irrigating solutions
4.9
7.2
22
45
S61.0
ICD-10 Finland
Open wound of finger(s) without damage to nail
1.2
7.2
826
6717
L25.9
ICD-10 Finland
Unspecified contact dermatitis, unspecified cause
2.1
7.2
74
348
Z88.9
ICD-10 Finland
Personal history of allergy to unspecified drugs, medicaments and biological substances
15.6
7.2
11
7
H70
ICPC
Otitis externa
1.6
7.2
165
1017
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
1.6
7.2
165
1017
R25.2
ICD-10 Finland
Cramp and spasm
1.6
7.2
173
1078
K11.5
ICD-10 Finland
Sialolithiasis
1.8
7.2
112
616
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.2
7.2
1336
11383
R06
ICD-10 Finland
Abnormalities of breathing
2.0
7.1
81
397
A11
ICPC
Chest pain NOS
1.3
7.1
483
3675
EB1MA
NOMESCO Finland
Cephalometry with X-ray
1.4
7.1
344
2483
L01BC06
ATC
capecitabine; oral
0.6
7.1
74
1326
G55.1
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders
2.0
7.1
87
438
L29.9
ICD-10 Finland
Pruritus, unspecified
1.6
7.1
174
1088
Z97.4
ICD-10 Finland
Presence of external hearing-aid
1.6
7.1
176
1107
K05.0
ICD-10 Finland
Acute gingivitis
1.5
7.1
233
1563
R94.2
ICD-10 Finland
Abnormal results of pulmonary function studies
2.5
7.1
50
195
S90.1
ICD-10 Finland
Contusion of toe(s) without damage to nail
1.6
7.1
193
1239
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
1.3
7.1
433
3249
J11
ICD-10 Finland
Influenza, virus not identified
1.8
7.1
109
595
J06.80
ICD-10 Finland
Continuously repeating infections of a child
3.8
7.1
28
74
Z05
ICPC
Work problem
1.7
7.1
140
826
SPAT1036
SPAT
Maxillary puncture
3.0
7.1
38
127
N30.2
ICD-10 Finland
Other chronic cystitis
2.3
7.0
62
270
R03AA01
ATC
epinephrine; inhalant
7.8
7.0
15
19
M03AX01
ATC
botulinum toxin; parenteral
1.8
7.0
122
691
ENC30
NOMESCO Finland
Plastic operation of pharynx
1.9
7.0
91
469
G01AF02
ATC
clotrimazole; vaginal
1.4
7.0
297
2092
50503
ICD-8 Finland
Nasal polyp, Ethmoidalis
5.0
7.0
21
42
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.3
7.0
462
3499
4453
FHL
Other and tonsil surgery
1.6
7.0
160
982
A06
ICPC
Fainting/syncope
1.8
7.0
103
555
F41.00
ICD-10 Finland
Moderate panic disorder
1.6
7.0
189
1211
S01GX07
ATC
azelastine; ophthalmic
6.0
7.0
18
30
W57
ICD-10 Finland
Bitten or stung by nonvenomous insect and other nonvenomous arthropods
1.5
7.0
226
1511
M53.2
ICD-10 Finland
Spinal instabilities
2.1
7.0
70
325
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
0.5
7.0
66
1213
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
1.6
7.0
189
1213
K10.3
ICD-10 Finland
Alveolitis of jaws
1.3
7.0
459
3479
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
1.5
7.0
258
1772
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.4
7.0
361
2634
G04BD07
ATC
tolterodine; oral
1.5
7.0
249
1697
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.4
7.0
309
2199
D01BA02
ATC
terbinafine; oral; topical
1.1
7.0
2002
17640
EMAK
NOMESCO Finland
NA
1.4
6.9
355
2585
K03.66
ICD-10 Finland
Tooth plaque
1.3
6.9
615
4852
K35.9
ICD-10 Finland
Acute appendicitis, unspecified
1.2
6.9
775
6284
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
2.2
6.9
64
285
L30
ICD-10 Finland
Other dermatitis
1.6
6.9
166
1034
K07.62
ICD-10 Finland
Habitual dislocation of the jaw joint
2.0
6.9
79
387
J01XC01
ATC
fusidic acid; systemic
1.9
6.9
102
548
62660
ICD-8 Finland
Disorders of menstruation, Intermenstrual bleeding
1.8
6.9
110
608
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
1.8
6.9
108
593
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
1.5
6.9
199
1294
SPAT1147
SPAT
Destruction of skin lesion with external methods
1.7
6.9
123
705
XA420
NOMESCO Finland
Extensive sleep examination
2.0
6.9
86
438
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
3.4
6.9
31
91
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.3
6.9
422
3165
Z10.0
ICD-10 Finland
Occupational health examination
1.3
6.9
642
5097
H10.8
ICD-10 Finland
Other conjunctivitis
2.0
6.9
83
416
S93.2
ICD-10 Finland
Rupture of ligaments at ankle and foot level
1.6
6.9
154
945
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
1.6
6.9
165
1028
XKD06
NOMESCO Finland
Physiologic investigation of micturition
1.6
6.9
165
1029
P74
ICPC
Anxiety disorder/anxiety state
1.3
6.8
450
3412
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
1.4
6.8
286
2011
R14
ICD-10 Finland
Flatulence and related conditions
2.1
6.8
71
334
WZC00
SPAT
NA
1.3
6.8
478
3657
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
1.6
6.8
184
1182
S50.0
ICD-10 Finland
Contusion of elbow
1.4
6.8
257
1772
N94.1
ICD-10 Finland
Dyspareunia
1.6
6.8
166
1037
SPAT1255
SPAT
Intravenous administration of medicine
1.3
6.8
435
3287
N41.0
ICD-10 Finland
Acute prostatitis
1.8
6.8
101
546
DM1AA
SPAT
NA
2.0
6.8
76
371
M65.4
ICD-10 Finland
Radial styloid tenosynovitis [de Quervain]
1.5
6.8
229
1546
FN1AD
NOMESCO Finland
CT of coronary arteries
1.9
6.8
95
505
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
1.8
6.7
99
535
NF1AA
NOMESCO Finland
Hip X-ray examination
1.3
6.7
448
3400
S02
ICPC
Pruritus
1.4
6.7
304
2168
N06AB08
ATC
fluvoxamine; oral
1.5
6.7
200
1313
F70
ICPC
Conjunctivitis infectious
1.5
6.7
212
1409
F17
ICPC
Glasses symptom/complaint
3.3
6.7
31
93
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.3
6.7
603
4765
3007
Kela drug reimbursment
Erenumab and fremanezumab
1.7
6.7
123
713
SPAT1098
SPAT
Exercise ECG
1.8
6.7
108
600
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.2
6.7
878
7240
R03DA05
ATC
aminophylline; systemic, rectal
2.9
6.7
39
136
D84.18
ICD-10 Finland
Other specified defect in the complement system
5.6
6.7
18
32
H03.1*B00.5
ICD-10 Finland
Herpesviral dermatitis of eyelid
2.8
6.7
40
143
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
2.0
6.7
79
392
G01AF01
ATC
metronidazole; vaginal
1.2
6.7
800
6535
130
Kela drug reimbursment
Malignant tumour
0.7
6.7
221
3087
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.6
6.7
165
1039
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
1.7
6.7
135
806
TCC30
NOMESCO Finland
Intubation of lacrimal canaliculus/duct
2.5
6.7
49
198
SPAT1251
SPAT
Organisation of medication
1.5
6.6
223
1504
K07.23
ICD-10 Finland
Deep bite
1.4
6.6
304
2174
L24.9
ICD-10 Finland
Irritant contact dermatitis, unspecified cause
2.3
6.6
55
236
I49.1
ICD-10 Finland
Atrial premature depolarization
1.5
6.6
203
1341
F43.8
ICD-10 Finland
Other reactions to severe stress
1.5
6.6
230
1563
G04AC01
ATC
NA
1.5
6.6
212
1417
S16
ICPC
Bruise/contusion
1.5
6.6
221
1491
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
1.5
6.6
221
1491
I47.1
ICD-10 Finland
Supraventricular tachycardia
1.4
6.6
302
2160
N05CD07
ATC
temazepam; oral
1.2
6.6
663
5312
Y96
ICD-10 Finland
Work-related condition
3.0
6.6
34
111
S03
ICPC
Warts
1.6
6.5
176
1129
Z71.9
ICD-10 Finland
Counselling, unspecified
1.3
6.5
479
3690
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
1.9
6.5
91
484
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.4
6.5
309
2225
G57.6
ICD-10 Finland
Lesion of plantar nerve
1.6
6.5
145
889
SPAT1377
SPAT
Polysomnography
1.4
6.5
254
1768
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.6
6.5
71
1250
F51
ICD-10 Finland
Nonorganic sleep disorders
1.4
6.5
345
2537
S81.0
ICD-10 Finland
Open wound of knee
1.6
6.4
148
915
P72
ICPC
Schizophrenia
0.5
6.4
56
1055
L30.0
ICD-10 Finland
Nummular dermatitis
1.5
6.4
216
1457
N02AC04
ATC
dextropropoxyphene; oral
1.6
6.4
164
1041
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
1.5
6.4
216
1459
S02AA30
ATC
antiinfectives, combinations; otic
1.3
6.4
552
4343
RJ630
NOMESCO Finland
NA
4.4
6.4
21
47
ZXX06
NOMESCO Finland
Extent of procedure, 6 units
3.6
6.4
26
71
K59.01
ICD-10 Finland
Constipation outlet obstruction type
2.0
6.4
77
388
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
1.5
6.4
174
1121
A02BD02
ATC
lansoprazole, tetracycline and metronidazole; systemic
1.6
6.4
137
833
Z56.7
ICD-10 Finland
Other and unspecified problems related to employment
2.5
6.3
45
176
7860C
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[SYNDROMA HYPERVENTILATIONIS]
4.2
6.3
22
52
78551
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD
1.5
6.3
186
1218
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
1.7
6.3
114
658
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
2.0
6.3
72
353
G47.8
ICD-10 Finland
Other sleep disorders
1.9
6.3
87
458
S49.9
ICD-10 Finland
Unspecified injury of shoulder and upper arm
1.7
6.3
123
727
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.4
6.3
283
2019
134
Kela drug reimbursment
General erythroderma
3.0
6.3
33
109
Y1202
ICD-8 Finland
Skin tests, Allergy tests
3.4
6.3
28
82
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.2
6.3
640
5134
H03.1
ICD-10 Finland
Involvement of eyelid in other infectious diseases classified elsewhere
3.8
6.3
24
62
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
1.6
6.3
151
943
M20.2
ICD-10 Finland
Hallux rigidus
1.5
6.3
181
1181
R19.4
ICD-10 Finland
Change in bowel habit
1.6
6.3
159
1006
L03.9
ICD-10 Finland
Cellulitis, unspecified
1.6
6.3
146
905
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
1.6
6.3
151
945
R03BB07
ATC
umeclidinium bromide; inhalant
2.5
6.3
46
186
RJ411
NOMESCO Finland
NA
2.5
6.3
46
186
D06BB10
ATC
imiquimod; topical
1.3
6.3
375
2806
SPAT1210
SPAT
Application of cast or individual aid
1.3
6.2
355
2636
WQ020
NOMESCO Finland
NA
5.9
6.2
16
27
L09
ICPC
Arm symptom/complaint
1.3
6.2
368
2747
TGC00
NOMESCO Finland
Bronchial lavation
1.6
6.2
144
892
G03FB05
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
1.2
6.2
675
5458
SPAT1044
SPAT
Tympanometry
1.5
6.2
194
1290
D12
ICPC
Constipation
1.5
6.2
194
1290
RF212
NOMESCO Finland
NA
2.9
6.2
34
116
U05
ICPC
Urination problems other
1.4
6.2
248
1735
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
2.7
6.2
38
139
NHL30
NOMESCO Finland
Suture or reinsertion of tendon of foot
2.0
6.2
69
337
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
1.5
6.2
183
1203
K60.2
ICD-10 Finland
Anal fissure, unspecified
1.6
6.2
140
862
NB1DG
NOMESCO Finland
Shoulder and humerus very extensive MRI examination with high intensity magnet
2.1
6.2
64
303
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
1.5
6.2
223
1530
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.6
6.2
153
965
F73
ICPC
Eye infection/inflammation other
1.6
6.2
167
1073
R43.0
ICD-10 Finland
Anosmia
2.2
6.2
56
249
SPAT1139
SPAT
Nutrition survey
1.4
6.2
240
1670
B01AF01
ATC
rivaroxaban; oral
1.3
6.2
582
4634
B01AB05
ATC
enoxaparin; parenteral
1.1
6.1
2288
20496
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
0.7
6.1
185
2626
W10
ICD-10 Finland
Fall on and from stairs and steps
1.3
6.1
360
2689
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
1.4
6.1
234
1622
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.4
6.1
244
1706
B05BB01
ATC
electrolytes; parenteral
4.0
6.1
22
54
EBA10
NOMESCO Finland
Surgical removal of tooth
1.2
6.1
1600
14000
R81
ICPC
Pneumonia
1.5
6.1
206
1391
I47.9
ICD-10 Finland
Paroxysmal tachycardia, unspecified
1.7
6.1
124
740
B00.11
ICD-10 Finland
Herpes simplex labialis
1.7
6.1
124
741
M19.8
ICD-10 Finland
Other specified arthrosis
1.5
6.1
191
1271
J01X
ATC
OTHER ANTIBACTERIALS
2.3
6.1
53
232
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
1.4
6.1
246
1723
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
1.4
6.1
260
1839
A03CA05
ATC
glycopyrronium bromide and psycholeptics; systemic
2.0
6.1
68
333
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.2
6.1
892
7441
H65
ICD-10 Finland
Nonsuppurative otitis media
1.9
6.1
81
424
F16
ICPC
Eyelid symptom/complaint
1.3
6.1
390
2950
WQ064
NOMESCO Finland
NA
12.4
6.0
10
8
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.2
6.0
849
7053
R43
ICPC
Respiratory, Other diagnostic procedure
2.2
6.0
58
266
XQ810
NOMESCO Finland
Physical test for urticaria
4.6
6.0
19
41
N81.6
ICD-10 Finland
Rectocele
1.3
6.0
414
3162
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
2.0
6.0
70
348
Z2446
NOMESCO Finland
Social worker
1.2
6.0
633
5103
M19.9
ICD-10 Finland
Arthrosis, unspecified
1.5
6.0
199
1340
DJD10
NOMESCO Finland
Closure of perforation of septum of nose
4.0
6.0
22
55
M89.0
ICD-10 Finland
Algoneurodystrophy
1.9
6.0
77
399
3027
Kela drug reimbursment
Benralizumab
8.5
6.0
12
14
R15
ICD-10 Finland
Faecal incontinence
1.6
6.0
145
910

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
199
57
34.99
314.02
1.1
1.1
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
215
82
26.30
309.94
1.1
1.0
u/ml
0.5
0.1
1.94
131
30
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
433
455
9.66
307.65
1.1
1.0
u/ml
10.9
9.2
0.24
95
42
(3003888) Timothy IgE Ab [Units/volume] in Serum
2004
2943
7.55
307.65
1.2
1.1
u/ml
7.8
5.5
4.83
1459
1399
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
264
94
28.26
307.65
1.1
1.1
u/ml
2.4
2.4
0.02
208
72
(4010399)
1918
7517
2.73
307.65
1.5
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
3107
8798
4.09
307.65
1.5
1.2
u/ml
464.4
181.8
13.90
2967
8088
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
275
61
45.40
307.65
1.0
1.0
u/ml
0.3
0.0
2.72
168
32
(3023430) Cat dander IgE Ab [Units/volume] in Serum
1267
2333
5.75
307.65
1.1
1.0
u/ml
7.6
5.3
2.43
757
910
(3008401) Mugwort IgE Ab [Units/volume] in Serum
1772
2876
6.73
307.65
1.1
1.1
u/ml
1.5
1.2
0.70
1152
1093
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
568
808
7.18
307.65
1.4
1.2
u/ml
1.1
0.9
0.24
242
314
(3014133) Dog dander IgE Ab [Units/volume] in Serum
1370
2489
5.86
307.65
1.1
1.1
u/ml
7.4
3.4
5.91
766
913
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
1056
2044
5.40
307.65
1.1
1.0
u/ml
0.5
0.4
0.20
387
363
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
253
87
29.24
307.65
1.1
1.0
u/ml
3.8
1.3
0.49
145
29
(3010726) Horse dander IgE Ab [Units/volume] in Serum
1889
2819
7.38
307.65
1.2
1.1
u/ml
3.3
1.7
4.08
624
682
(3011841) English Walnut IgE Ab [Units/volume] in Serum
288
91
31.89
307.65
1.1
1.1
u/ml
5.2
3.1
0.42
227
71
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
443
169
26.66
307.65
1.2
1.1
u/ml
8.3
10.7
0.19
333
109
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
2056
3360
6.79
307.65
1.2
1.1
u/ml
2.1
1.7
0.92
1218
1229
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
244
91
26.94
307.65
1.1
1.0
u/ml
0.7
1.0
0.14
148
30
(3013115) Eosinophils [#/volume] in Blood
9078
66189
1.81
286.73
6.0
6.4
e9/l
0.2
0.2
66.34
8182
58949
(3011897) Casein IgE Ab [Units/volume] in Serum
274
218
12.64
278.73
1.4
1.2
u/ml
22.6
0.7
1.98
60
51
(3027231) Wheat IgE Ab [Units/volume] in Serum
300
280
10.79
275.18
1.2
1.0
u/ml
2.4
2.3
—
19
6
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
165
43
38.38
266.97
1.0
1.0
u/ml
1.3
3.5
0.27
129
28
(3012494) Peanut IgE Ab [Units/volume] in Serum
355
440
8.15
262.78
1.2
1.1
u/ml
12.8
32.6
0.38
271
241
(3006315) Basophils [#/volume] in Blood
8694
63920
1.75
253.53
5.8
6.1
e9/l
0.0
0.0
4.85
7743
56017
(3001604) Monocytes [#/volume] in Blood
8670
63705
1.75
253.27
5.8
6.1
e9/l
0.5
0.6
0.72
7734
55881
(3019198) Lymphocytes [#/volume] in Blood
8940
66354
1.75
251.03
5.8
6.1
e9/l
2.0
2.0
0.61
8117
59332
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
172
64
26.89
249.98
1.0
1.0
u/ml
1.6
1.8
0.06
123
44
(3000492) Spirometry study
2498
12781
2.11
225.96
1.5
1.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
7898
57926
1.68
219.92
5.9
6.3
%
0.7
0.7
3.89
7424
54417
(3019069) Monocytes/100 leukocytes in Blood
8149
60317
1.68
218.63
6.1
6.5
%
8.2
8.2
1.69
7705
56998
(3006504) Eosinophils/100 leukocytes in Blood
8108
59962
1.68
218.00
5.8
6.2
%
3.4
2.8
71.06
7634
56291
(3018010) Neutrophils/100 leukocytes in Blood
8318
62038
1.67
215.55
5.7
6.0
%
55.1
55.9
10.16
7859
58614
(3019420) Tryptase [Mass/volume] in Serum or Plasma
352
544
6.53
213.67
1.3
1.5
ug/l
6.3
7.1
0.45
321
494
(3002030) Lymphocytes/100 leukocytes in Blood
8400
62938
1.67
212.72
5.9
6.2
%
30.0
29.9
0.89
7924
59272
(3013650) Neutrophils [#/volume] in Blood by Automated count
9428
73381
1.65
200.41
7.5
9.1
e9/l
3.9
4.0
2.40
8392
64408
(3013707) Erythrocyte sedimentation rate by Westergren method
11270
92600
1.67
186.37
4.3
3.8
mm/h
9.4
9.8
4.15
10601
86734
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
127
47
26.96
184.79
1.1
1.0
u/ml
24.5
19.0
0.26
109
36
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
331
635
5.25
160.29
1.1
1.1
u/ml
13.1
11.4
0.26
123
88
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
132
76
17.33
160.10
1.1
1.0
u/ml
11.5
6.2
1.43
108
35
(42870588) Differential panel, method unspecified - Blood
5832
41895
1.59
159.69
5.7
6.3
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
119
79
15.02
134.18
1.7
1.3
u/ml
12.5
5.1
0.60
107
56
(3020874) Milk IgE Ab [Units/volume] in Serum
429
1162
3.73
133.49
1.3
1.1
u/ml
8.2
0.6
2.23
236
320
(3016031) Almond IgE Ab [Units/volume] in Serum
112
80
13.95
121.27
1.0
1.1
u/ml
1.2
0.6
1.21
79
50
(3014599) Egg white IgE Ab [Units/volume] in Serum
399
1132
3.55
115.84
1.3
1.0
u/ml
10.8
3.9
0.94
229
256
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
14575
133310
1.82
111.69
12.4
11.0
mg/l
18.4
21.0
21.53
11518
101548
(3015076) Soybean IgE Ab [Units/volume] in Serum
365
1012
3.63
109.69
1.2
1.0
u/ml
1.2
1.0
0.14
108
123
(3007164) IgA [Mass/volume] in Serum or Plasma
4204
30047
1.52
107.90
1.5
1.4
g/l
2.2
2.2
0.03
2582
18969
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
4763
35015
1.49
106.39
1.4
1.3
u/ml
1.5
1.8
0.75
1313
9695
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
3235
21908
1.58
105.61
1.3
1.3
u/ml
9.4
10.5
0.30
1324
9097
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
11944
104627
1.50
104.32
4.4
4.0
pmol/l
14.6
14.5
3.00
11045
96834
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
3341
23157
1.54
97.26
1.3
1.3
iu/ml
21.6
31.4
3.63
945
7089
(3048689) Calprotectin [Mass/mass] in Stool
2863
19504
1.55
89.15
2.6
2.6
ug/g
106.9
121.9
1.88
2220
15461
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
13401
121431
1.54
88.51
5.2
4.6
mu/l
2.2
2.1
0.20
12602
114125
(3037522) Nuclear Ab [Titer] in Serum
2748
18874
1.53
81.62
1.4
1.4
titre
463.2
539.6
1.40
497
3727
(3021589) Normoblasts [#/volume] in Blood
7023
57460
1.37
79.52
8.2
8.7
e9/l
0.0
0.0
3.02
5804
47104
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
10480
91448
1.38
78.60
6.7
6.9
u/l
75.1
76.4
2.54
9885
86438
(3019550) Sodium [Moles/volume] in Serum or Plasma
13969
128648
1.54
75.95
12.1
11.6
mmol/l
139.6
139.6
0.28
13609
125210
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
102
127
8.00
75.21
1.1
1.1
u/ml
0.0
0.1
0.40
61
79
(3023103) Potassium [Moles/volume] in Serum or Plasma
14000
129066
1.54
74.99
12.2
11.7
mmol/l
3.9
3.9
5.12
13600
125315
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
220
577
3.81
71.77
1.7
2.5
ug/l
109.5
73.9
0.15
209
545
(44813793)
332
1128
2.95
71.64
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
872
4538
1.95
71.36
1.4
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
4780
37260
1.38
70.74
1.8
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
4792
37420
1.38
69.98
3.0
2.8
ng/l
26.3
62.2
1.40
2513
19685
(3036312) Salmon IgE Ab [Units/volume] in Serum
79
78
10.07
69.62
1.1
1.1
u/ml
2.7
0.5
2.00
65
57
(3001122) Ferritin [Mass/volume] in Serum or Plasma
7576
63611
1.34
68.45
3.0
2.9
ug/l
91.8
90.7
0.09
7152
60120
(40768797) Stomach Pathology biopsy report
2242
15278
1.53
67.84
1.2
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
3680
27603
1.41
67.80
1.9
1.9
mg/l
0.8
1.0
3.91
2653
20401
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
807
4177
1.96
67.03
1.2
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
6283
51472
1.34
66.40
2.5
2.3
nmol/l
76.3
1788.6
0.50
5805
47827
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1841
12066
1.58
66.27
2.2
2.1
nmol/l
357.2
373.6
3.34
1692
11137
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
5234
41797
1.35
65.22
1.9
1.8
pmol/l
100.3
98.2
2.32
2791
22262
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
78
83
9.35
65.11
1.0
1.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
2082
14105
1.53
64.47
1.7
1.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
265
841
3.16
64.39
2.5
1.8
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
162
378
4.28
62.03
1.2
1.2
g/l
0.3
0.3
0.30
126
312
(3037467) Urinalysis macro (dipstick) panel - Urine
9896
87043
1.32
61.37
4.3
3.9
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
358
1374
2.62
61.29
1.4
1.3
g/l
2.9
2.9
0.07
290
943
(3024139) IgG subclass 3 [Mass/volume] in Serum
357
1375
2.61
60.68
1.4
1.3
g/l
0.3
0.4
2.32
290
944
(3027135) IgG subclass 1 [Mass/volume] in Serum
356
1375
2.60
60.17
1.4
1.3
g/l
6.3
6.8
2.91
289
941
(4062490)
355
1382
2.58
59.05
1.5
1.4
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
147
334
4.39
58.27
1.2
1.2
%
114.0
109.0
1.37
134
304
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
747
3949
1.92
58.17
1.6
1.9
g/l
0.2
0.2
0.11
704
3796
(3000494) Fungus identified in Specimen by Culture
2005
13771
1.50
57.70
1.6
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
761
4078
1.89
56.84
1.6
1.8
g/l
1.2
1.2
1.07
718
3927
(40760892) CBC W Ordered Manual Differential panel - Blood
3985
31067
1.36
56.23
4.1
4.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
1439
9261
1.59
55.47
2.5
2.3
au/ml
22.3
22.2
0.01
101
676
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
1339
8543
1.60
53.46
1.3
1.3
au/ml
46.9
45.1
0.08
48
328
(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum
46
31
14.73
51.32
1.0
1.0
u/ml
1.8
0.1
0.79
28
12
(40758558) Short blood count panel - Blood
3988
31472
1.34
50.97
5.6
7.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
9307
82205
1.28
50.51
4.3
3.9
e6/l
1704.3
1441.4
0.16
119
994
(3005719) IgG [Mass/volume] in Serum or Plasma
1489
9858
1.55
50.49
2.6
2.7
g/l
10.0
10.5
6.10
1372
9074
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
6327
53278
1.29
50.02
5.9
6.5
mmol/l
1.2
1.2
4.96
5452
45342
(40761511) CBC panel - Blood by Automated count
14862
140743
1.55
49.94
11.2
10.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1811
12539
1.48
49.58
3.9
3.7
%
31.5
32.0
1.30
1284
9115
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
3656
28584
1.34
49.51
2.3
2.2
mg/l
2.7
2.8
1.63
3157
24716
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
11971
109458
1.32
48.86
4.9
4.5
mmol/mol
38.2
38.2
0.27
11246
103342
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
276
1043
2.65
48.81
1.1
1.1
iu/ml
5.8
7.8
0.72
56
285
(36660697) Celiac disease serology panel - Serum
1815
12611
1.48
48.77
1.2
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
3880
30660
1.33
48.75
2.1
2.1
u/l
159.9
208.6
3.32
3658
28995
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
12946
119742
1.35
48.64
4.0
3.7
mmol/l
5.7
5.7
0.63
12075
111821
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
12867
118943
1.35
48.21
10.2
9.7
ml/min/173m2
90.9
91.1
0.27
10517
96104
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
47
37
12.61
47.99
1.1
1.0
u/ml
0.6
0.1
1.38
29
11
(3024980) IgG subclass 4 [Mass/volume] in Serum
460
2194
2.11
47.82
1.6
1.6
g/l
0.7
0.7
0.21
382
1661
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
42
28
14.89
47.10
1.0
1.0
u/ml
1.4
0.2
1.16
33
21
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
12036
110367
1.31
46.55
4.0
3.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
475
2326
2.05
46.03
1.2
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2883
21944
1.37
46.02
2.7
2.9
ng/l
719.0
945.8
2.58
2292
18178
(3007461) Platelets [#/volume] in Blood
15740
151719
1.94
44.09
18.0
16.2
e9/l
264.1
260.1
13.43
15487
148247
(3023419) Bacteria identified in Sputum by Culture
258
997
2.59
43.66
2.7
2.8
—
—
—
0
0
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
46
41
11.14
43.44
1.0
1.0
u/ml
0.6
0.1
1.17
29
17
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
513
2637
1.96
43.36
1.2
1.1
au/ml
14.1
11.2
0.27
30
187
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
144
400
3.59
43.36
1.2
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
1828
12997
1.44
43.23
1.3
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
4446
36318
1.29
42.74
2.4
2.5
u/l
56.1
57.3
0.54
4108
33693
(3035941) MCH [Entitic mass]
15746
151881
1.93
42.70
17.9
16.1
pg
30.0
30.0
0.67
15625
150192
(3047007) Chlamydophila sp Ab [Presence] in Serum
471
2364
2.00
42.63
1.3
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
15745
151892
1.92
42.31
17.9
16.1
fl
89.9
89.9
0.62
15622
150201
(3000963) Hemoglobin [Mass/volume] in Blood
15752
151982
1.93
42.30
18.0
16.3
g/l
137.0
136.3
9.12
15635
150297
(3026361) Erythrocytes [#/volume] in Blood
15747
151919
1.93
42.29
18.0
16.2
e12/l
4.6
4.6
9.97
15458
148163
(3028026) IgM [Mass/volume] in Serum or Plasma
1168
7624
1.56
41.92
1.8
1.8
g/l
1.2
1.3
1.23
1064
7088
(3025018) Bordetella pertussis Ab [Titer] in Serum
252
983
2.56
41.84
1.2
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
15749
151973
1.92
41.83
18.0
16.2
e9/l
6.7
6.7
3.93
15459
148181
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
14750
140110
1.47
41.72
9.5
8.8
u/l
26.8
26.8
0.19
14339
136026
(40768804) Tissue Pathology biopsy report
5901
50035
1.26
41.66
2.0
1.9
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
93
192
4.82
41.57
1.1
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
5685
48002
1.27
41.54
5.5
6.0
mmol/l
1.2
1.2
3.03
5154
44040
(3002179) Metamyelocytes/100 leukocytes in Blood
1321
8956
1.50
39.68
3.6
4.1
%
0.5
0.6
0.93
207
1816
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
6788
58755
1.25
39.27
4.9
5.8
umol/l
10.8
10.8
0.00
6375
55420
(3013826) Glucose [Moles/volume] in Serum or Plasma
7720
67781
1.24
39.27
4.3
4.4
mmol/l
6.4
6.4
0.58
7146
61946
(3009445) Proteinase 3 Ab [Units/volume] in Serum
776
4678
1.67
38.58
1.8
1.6
u/ml
14.5
11.1
0.24
24
164
(3025159) Blasts/100 leukocytes in Blood
1304
8901
1.49
37.82
4.1
4.4
%
0.0
0.2
1.82
227
1966
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
35
25
13.89
37.75
1.0
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
1353
9324
1.48
37.40
4.0
4.4
%
0.1
0.1
0.88
253
2315
(3013512) EKG study
3485
27980
1.30
37.31
3.3
3.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
865
5412
1.62
37.11
1.8
1.7
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
63
103
6.08
36.33
1.1
1.0
u/ml
2.5
0.1
0.63
29
29
(3017181) Myelocytes/100 leukocytes in Blood
1396
9737
1.46
36.22
4.0
4.3
%
0.8
0.9
0.66
271
2483
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
1305
9000
1.47
35.88
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
1363
9512
1.46
35.23
3.6
3.8
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
37
34
10.80
34.22
1.1
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
853
5433
1.59
33.93
1.3
1.3
u/ml
0.4
1.0
2.80
81
460
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
804
5115
1.59
32.12
1.6
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1697
12539
1.38
31.58
4.7
5.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
2129
16309
1.34
31.36
1.6
1.7
nmol/l
1142.1
1176.5
1.07
1645
12681
(3021960) Folate [Moles/volume] in Serum or Plasma
2824
22553
1.29
30.66
1.5
1.5
nmol/l
20.6
20.4
0.36
2480
19827
(3009261) Glucose [Presence] in Urine by Test strip
7175
63514
1.21
30.50
3.4
3.2
estimate
0.0
0.0
0.48
1371
12092
(3021601) Nitrite [Presence] in Urine by Test strip
7121
63016
1.21
30.29
4.6
4.4
estimate
0.0
0.0
2.81
1406
12403
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
626
3805
1.65
30.13
1.7
1.6
titre
270.4
350.6
0.27
23
153
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
620
3764
1.66
29.98
1.3
1.3
u/ml
53.5
31.2
0.84
32
239
(3026493) Urate [Moles/volume] in Serum or Plasma
3433
28246
1.26
28.98
2.3
2.4
umol/l
2660.9
2877.7
0.16
3023
25239
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
546
3237
1.69
28.90
1.9
2.1
mg/l
10.1
10.5
0.83
501
3052
(3013139) Helicobacter pylori Ag [Presence] in Stool
1214
8606
1.43
28.65
1.2
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
1151
8092
1.44
28.42
1.2
1.1
titre
90.8
233.5
2.73
31
232
(40768443) Skin Pathology biopsy report
745
4790
1.57
28.42
1.2
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
7077
62842
1.20
28.30
3.4
3.2
estimate
0.0
0.0
1.28
1365
11972
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
787
5132
1.55
28.19
2.0
2.0
u/l
39.0
39.9
0.71
708
4701
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
10183
93590
1.21
28.00
3.1
2.9
u/l
38.9
39.6
0.39
9640
89176
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
516
3039
1.70
28.00
1.4
1.5
iu/ml
23.0
11.3
0.47
11
72
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
152
566
2.68
27.88
1.0
1.0
—
—
—
0
0
(3015736) pH of Urine
5583
48571
1.21
27.43
3.1
3.0
ph
5.8
5.9
—
6
24
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
13182
124511
1.26
27.27
4.0
3.7
mmol/l
1.5
1.5
2.86
12442
117771
(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum
35
41
8.47
27.14
1.0
1.0
u/ml
10.0
12.4
0.21
28
31
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
13262
125376
1.26
27.10
4.0
3.7
mmol/l
4.7
4.8
1.04
12544
118865
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
12750
120048
1.24
26.71
3.6
3.3
mmol/l
1.3
1.3
4.07
11998
113233
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
13363
126490
1.26
26.71
4.3
4.0
mmol/l
2.9
2.9
1.03
12580
119172
(3004616) Nuclear Ab [Presence] in Serum
295
1492
1.98
26.26
1.4
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
559
3440
1.63
25.64
1.3
1.3
u/ml
11.5
9.7
0.15
69
545
(3042936) Bacteria identified in Isolate by Culture
1985
15461
1.31
25.62
2.0
1.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
4301
36688
1.22
25.35
2.6
3.2
mmol/l
2.4
2.4
1.52
3745
32811
(3017732) Neutrophils [#/volume] in Blood
1241
9048
1.39
24.81
2.1
2.5
e9/l
4.3
4.1
0.69
954
7536
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
549
3391
1.62
24.81
1.3
1.3
u/ml
8.3
8.0
0.02
44
350
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
651
4197
1.56
24.54
1.7
2.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
2161
17118
1.29
24.46
2.2
2.4
umol/l
14.5
14.2
1.63
2007
16027
(3008898) HLA-B27 [Presence]
890
6131
1.46
24.42
1.1
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
4808
41580
1.21
24.40
3.6
3.4
e6/l
58.3
76.8
1.74
3266
27885
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
2672
21787
1.26
23.78
1.6
1.6
pmol/l
23020774.0
33456607.9
0.56
2311
18723
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
21
14
14.87
23.37
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
1527
11648
1.33
22.73
1.3
1.2
iu/ml
137.4
149.9
0.44
574
4475
(3007700) Barley IgE Ab [Units/volume] in Serum
41
70
5.81
22.70
1.1
1.0
u/ml
26.2
0.5
0.49
28
32
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
267
1388
1.92
22.01
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
267
1388
1.92
22.01
1.4
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
207
984
2.10
21.94
1.5
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
3629
30802
1.21
21.90
3.0
2.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2007
15960
1.28
21.85
1.8
1.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
12265
115682
1.21
21.75
14.0
13.5
%
13.4
13.5
2.20
12090
113347
(3025468) Yersinia sp identified in Specimen by Organism specific culture
264
1375
1.92
21.65
1.4
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1239
9228
1.36
21.62
2.9
3.4
pmol/l
4.6
4.6
0.86
1090
8343
(3024561) Albumin [Mass/volume] in Serum or Plasma
5319
46803
1.19
21.61
4.3
4.8
g/l
37.0
36.6
6.47
4939
43698
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
270
1419
1.90
21.55
1.4
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
264
1380
1.91
21.42
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
263
1379
1.90
21.15
1.4
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
697
4733
1.48
20.58
3.9
4.8
mmol/l
24.5
24.5
0.02
666
4507
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
2638
21796
1.24
20.53
1.5
1.5
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
3624
30922
1.21
20.49
3.1
2.9
e6/l
0.2
0.3
3.17
2714
22772
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
31
44
6.99
20.48
1.0
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
931
6685
1.40
20.32
3.6
4.5
mmol/l
1.2
1.4
1.29
661
4815
(3009343) pH of Capillary blood
954
6879
1.40
20.31
3.6
4.5
ph
7.4
7.4
0.15
76
799
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
239
1232
1.93
20.25
1.1
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
1113
8244
1.36
20.09
1.2
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
742
5125
1.45
20.08
3.7
4.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
592
3916
1.52
19.88
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
589
3902
1.51
19.64
1.2
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
3082
25986
1.22
19.58
3.7
4.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
958
6957
1.39
19.55
3.7
4.5
kpa
5.1
5.1
0.23
911
6523
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1940
15578
1.26
19.35
2.2
2.4
g/l
2.5
2.4
5.09
1806
14543
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
470
2976
1.58
19.22
1.2
1.3
u/ml
44.1
40.2
0.17
48
286
(3017446) Testosterone [Moles/volume] in Serum or Plasma
1179
8883
1.34
19.01
2.4
2.1
nmol/l
12.3
12.0
0.53
1071
7936
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
579
3870
1.50
18.51
1.2
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
8721
80467
1.16
18.26
3.2
3.0
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
39
78
4.96
18.24
1.1
1.0
u/ml
35.7
0.1
0.50
25
26
(1002224) Polysomnography panel
864
6248
1.39
18.08
1.1
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
670
4643
1.45
17.84
1.1
1.1
u/ml
4.0
5.7
0.88
94
684
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
60
170
3.50
17.78
1.1
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
430
2721
1.58
17.67
1.2
1.3
u/ml
1.5
3.9
1.33
27
210
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
407
2547
1.60
17.53
1.4
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
2761
23268
1.21
17.39
2.5
2.5
e6/l
5.9
6.8
2.88
2400
20313
(3002582) Erythrocytes [#/volume] in Urine
3897
33897
1.18
17.26
3.1
3.0
e6/l
43.7
75.4
2.02
2977
25478
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
3259
27922
1.20
17.16
2.3
2.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
333
1996
1.67
17.07
1.4
1.2
titre
92.5
196.7
—
8
42
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
160
764
2.08
16.88
3.8
4.3
—
—
—
0
0
(3026782) Osmolality of Urine
2560
21474
1.21
16.86
2.7
2.6
mosm/kgh2o
537.5
548.0
1.41
2150
18314
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
473
3092
1.53
16.84
1.4
1.4
u/l
23.1
23.3
0.04
372
2565
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
5500
49249
1.16
16.79
3.4
3.2
—
—
—
0
0
(3003843) Paprika IgE Ab [Units/volume] in Serum
24
32
7.44
16.73
1.0
1.0
u/ml
0.2
0.0
0.64
19
20
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1763
14235
1.25
16.64
2.3
2.5
%
23.9
23.8
0.21
1552
12399
(3026389) Candida sp identified in Specimen by Organism specific culture
327
1979
1.65
16.17
1.3
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
415
2668
1.55
15.95
2.5
2.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
3534
30679
1.18
15.80
2.4
2.2
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
51
141
3.59
15.72
1.2
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1345
10589
1.28
15.65
1.7
1.6
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
854
6314
1.36
15.58
1.1
1.1
u/ml
26.8
6.9
0.34
17
83
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
395
2536
1.56
15.29
1.6
1.6
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
108
459
2.34
15.22
1.5
1.3
titre
36.9
64.4
0.85
13
43
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
390
2533
1.54
14.36
2.4
2.1
g/l
0.6
0.7
0.22
341
2231
(3009508) Creatinine [Moles/volume] in Urine
3792
33327
1.17
14.31
3.2
3.3
mmol/l
8.1
8.1
0.48
3289
28916
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
108
473
2.27
14.22
1.5
1.3
titre
108.0
298.9
—
5
27
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1347
10731
1.27
14.19
1.7
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
882
6661
1.33
13.98
1.3
1.3
—
—
—
0
0
(4015189)
59
193
3.03
13.96
3.1
2.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
30
61
4.88
13.81
3.0
1.4
umol/l
40.8
44.1
0.22
30
61
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
52
161
3.21
13.50
1.7
1.7
mg/l
1.0
2.0
1.24
39
110
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
2196
18520
1.20
13.42
2.7
2.6
e6/l
0.9
1.1
2.14
1251
10093
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
587
4186
1.40
13.40
1.9
1.7
nmol/l
39.3
40.3
0.41
575
4103
(3020717) Zinc [Moles/volume] in Serum or Plasma
152
778
1.94
13.33
1.5
1.7
umol/l
25.6
23.8
0.30
146
746
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
51
158
3.20
13.24
1.7
1.7
mg/l
2.4
1.9
0.25
43
114
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
51
158
3.20
13.24
1.7
1.7
mg/l
3.3
3.1
0.05
41
104
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
51
158
3.20
13.24
1.7
1.7
mg/l
1.9
1.7
0.13
43
110
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
51
158
3.20
13.24
1.7
1.7
mg/l
3.2
2.8
0.13
41
108
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
51
158
3.20
13.24
1.7
1.7
mg/l
1.3
1.9
0.63
36
99
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
51
158
3.20
13.24
1.7
1.7
mg/l
3.8
4.1
0.15
41
93
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
51
158
3.20
13.24
1.7
1.7
mg/l
1.1
1.0
0.06
41
106
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
51
158
3.20
13.24
1.7
1.7
mg/l
1.9
2.0
0.05
38
104
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
51
158
3.20
13.24
1.7
1.7
mg/l
1.4
1.2
0.14
38
102
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
115
534
2.14
13.16
1.4
1.5
u/ml
27.6
19.2
0.47
16
107
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
420
2833
1.48
12.95
2.2
2.1
g/l
2.9
3.0
1.93
324
2239
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
354
2307
1.53
12.88
2.1
2.0
g/l
38.8
38.4
0.54
309
2029
(3020630) Protein [Mass/volume] in Serum or Plasma
905
6941
1.31
12.85
2.3
2.4
g/l
67.2
67.0
0.31
822
6441
(3000570) Elastase.pancreatic [Mass/mass] in Stool
455
3123
1.46
12.84
1.4
1.4
ug/g
306.6
289.8
0.90
232
1704
(3004588) Protein electrophoresis panel - Serum or Plasma
720
5348
1.35
12.78
2.1
2.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
797
6012
1.33
12.75
1.5
1.5
u/l
8.7
9.3
0.72
648
4867
(3011397) Hemoglobin [Presence] in Urine by Test strip
3271
28646
1.16
12.70
3.5
3.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
3060
26698
1.17
12.44
3.4
3.3
mg/l
569.7
416.0
0.76
1912
17119
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
434
2973
1.46
12.39
2.2
2.1
g/l
7.1
7.3
1.74
335
2279
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
81
333
2.42
12.38
1.1
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
338
2201
1.53
12.37
1.3
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
338
2202
1.53
12.34
1.3
1.2
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
169
920
1.83
12.30
1.3
1.2
u/ml
39.2
44.4
—
6
55
(3029937) Albumin [Presence] in Urine by Test strip
3766
33396
1.15
12.28
3.7
3.5
estimate
0.0
0.0
0.02
1384
12061
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
433
2971
1.46
12.26
2.2
2.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4755
42857
1.14
12.21
3.0
3.2
u/l
30.6
32.4
1.32
4538
40867
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
406
2758
1.47
12.11
2.1
2.1
g/l
9.5
10.3
3.37
337
2356
(3017958) Strawberry IgE Ab [Units/volume] in Serum
24
45
5.29
12.10
1.0
1.0
u/ml
0.3
0.0
1.07
17
22
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
432
2971
1.45
12.09
2.2
2.1
g/l
3.8
3.8
0.50
317
2164
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
190
1078
1.75
12.05
2.1
2.9
e6/l
534.3
532.7
0.02
161
864
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
957
7475
1.28
11.84
1.7
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
613
4500
1.36
11.77
1.6
1.6
iu/ml
0.2
5.2
0.74
134
936
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
347
2300
1.50
11.71
2.2
2.0
g/l
0.0
0.0
0.17
320
2123
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
399
2720
1.46
11.71
2.1
1.8
pmol/l
194.0
189.9
0.32
386
2598
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
3271
28808
1.16
11.65
2.1
2.2
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
186
1060
1.75
11.64
2.1
2.9
e9/l
0.2
0.2
0.17
160
866
(3018418) pH of Serum or Plasma
3512
31092
1.15
11.63
3.5
3.9
ph
7.4
7.4
0.25
676
6035
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
265
1662
1.59
11.48
1.9
1.4
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
163
898
1.81
11.45
1.3
1.2
u/ml
36.7
60.0
—
6
45
(3011412) CD3 cells [#/volume] in Blood
231
1403
1.64
11.42
2.1
2.7
e9/l
1.4
1.2
2.64
142
842
(3045683) HLA typing for celiac disease panel - Blood or Tissue
185
1059
1.74
11.41
1.0
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
4357
39197
1.14
11.34
6.3
6.5
inr
1.1
1.1
0.20
1344
12459
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
163
902
1.80
11.29
1.3
1.2
u/ml
103.2
41.8
—
9
73
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
198
1159
1.70
11.27
2.0
1.9
mg/l
15.9
25.2
2.89
47
322
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
18
28
6.37
10.94
1.3
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
794
6132
1.30
10.74
1.6
1.6
mg/l
3.5
3.5
0.01
553
4150
(3020682) Albumin/Creatinine [Ratio] in Urine
3165
27955
1.15
10.71
4.0
4.1
mg/mmol
8.7
10.4
0.82
1991
18158
(3007456) Orange IgE Ab [Units/volume] in Serum
19
32
5.89
10.70
1.1
1.0
u/ml
0.1
0.1
0.11
14
21
(3013005) Retinol [Moles/volume] in Serum or Plasma
144
781
1.83
10.68
2.3
2.2
umol/l
2.0
1.8
1.38
133
738
(3004716) Salmonella sp identified in Stool by Organism specific culture
1138
9189
1.24
10.64
1.4
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
313
2077
1.50
10.55
2.2
2.0
g/l
0.0
0.0
0.00
288
1926
(3041096) Erythrocytes [Presence] in Urine by Automated
4032
36263
1.13
10.36
2.9
2.8
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
155
868
1.78
10.36
1.3
1.2
u/ml
15.6
10.1
0.25
16
72
(3025296) Carrot IgE Ab [Units/volume] in Serum
18
30
5.95
10.24
1.1
1.0
u/ml
3.0
0.2
—
13
9
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
314
2101
1.49
10.18
2.2
2.0
g/l
0.0
0.0
0.37
288
1931
(40761535) Cells panel - Urine sediment
1049
8442
1.25
10.11
3.4
3.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
76
337
2.24
9.87
4.7
4.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
3107
27570
1.14
9.73
3.5
3.4
kg/l
1.0
1.0
0.86
441
4020
(3021661) Pineapple IgE Ab [Units/volume] in Serum
13
16
8.05
9.61
1.0
1.0
u/ml
0.3
0.1
—
8
7
(3045716) Anion gap in Serum or Plasma
85
402
2.10
9.42
2.6
2.4
mmol/l
9.1
9.5
0.39
73
303
(3044640) Blood type and Crossmatch panel - Blood
4204
38139
1.12
9.18
2.2
2.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
78
362
2.14
9.09
1.2
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
3667
33018
1.13
9.06
2.8
2.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
2020
17488
1.16
8.85
2.9
2.7
e6/l
3.2
3.5
0.58
1077
9076
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
236
1535
1.53
8.83
2.4
2.8
nmol/l
22.3
21.6
0.39
227
1472
(3009542) Hematocrit [Volume Fraction] of Blood
13419
129771
1.14
8.68
12.8
11.8
%
40.5
40.3
2.40
10868
104819
(3024354) Oxygen [Partial pressure] in Venous blood
988
8041
1.23
8.61
4.0
4.5
kpa
4.7
4.8
0.74
952
7787
(3024891) Influenza virus A+B Ag [Presence] in Specimen
530
4000
1.32
8.56
1.1
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
178
1097
1.61
8.43
2.0
2.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1969
17080
1.16
8.39
3.1
4.0
mmol/l
0.8
0.8
1.96
1810
16074
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2163
18898
1.15
8.36
3.2
3.2
ng/l
292.2
516.1
1.48
1282
11899
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
170
1042
1.62
8.24
1.2
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
545
6953
0.77
8.22
1.5
1.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
71
333
2.12
8.10
1.1
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
169
1042
1.61
8.02
3.3
2.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
55
234
2.33
7.95
1.3
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
413
5430
0.75
7.78
1.4
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
167
1037
1.60
7.71
1.2
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1309
11068
1.19
7.66
2.2
2.5
u/l
37.3
42.3
0.47
1119
9531
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2300
20304
1.14
7.63
4.1
3.8
ug/l
1.8
2.1
1.81
2087
18494
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2044
17901
1.15
7.61
2.3
2.8
mmol/l
2.4
2.4
3.57
1764
15626
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
13
21
6.13
7.61
1.0
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
358
2600
1.37
7.51
1.1
1.1
u/ml
3.1
2.9
0.13
166
1349
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
670
5306
1.26
7.50
1.6
1.6
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1149
9622
1.20
7.50
4.4
4.9
kpa
5.9
5.9
0.06
1109
9337
(3039162) Centromere protein B Ab [Units/volume] in Serum
254
1739
1.45
7.47
1.2
1.3
u/ml
40.4
52.6
—
9
112
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
161
1000
1.60
7.45
2.0
3.0
e6/l
795.3
813.4
0.10
64
373
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1833
15968
1.15
7.35
3.5
3.4
%
20.9
21.5
0.89
666
6213
(3006245) CD3-CD19+ cells/100 cells in Blood
125
732
1.70
7.29
2.0
2.9
%
11.1
11.6
0.27
120
706
(3012544) pH of Venous blood
1175
9893
1.19
7.22
4.3
4.8
ph
7.4
7.4
—
6
53
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
636
5030
1.26
7.22
2.4
2.3
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
52
226
2.28
7.19
1.0
1.1
—
30.2
—
0
6
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
871
7140
1.22
7.12
1.8
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
554
4330
1.28
6.95
2.0
2.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
254
1767
1.43
6.89
1.1
1.1
g/l
1.4
1.5
2.63
223
1617
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
511
6417
0.78
6.85
1.8
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
348
2556
1.36
6.84
1.1
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
476
3657
1.30
6.84
1.2
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
756
6136
1.23
6.82
1.5
1.5
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
130
785
1.65
6.78
1.7
1.8
%
123.9
127.9
0.26
125
739
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
152
955
1.58
6.75
1.3
1.4
nmol/l
1.7
1.4
1.56
137
860
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
784
6414
1.22
6.56
1.4
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
178
1170
1.51
6.47
2.0
2.4
%
11.6
12.4
0.59
118
661
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
901
7502
1.20
6.30
3.6
4.3
ng/l
73.3
82.4
3.26
798
6696
(3035637) Corticotropin [Mass/volume] in Plasma
246
1735
1.41
6.23
1.6
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
153
982
1.55
6.23
1.4
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
1127
9585
1.18
6.18
4.4
4.9
mmol/l
1.9
1.7
0.73
924
7758
(3021387) Prolactin [Units/volume] in Serum or Plasma
950
7967
1.19
6.14
1.7
1.6
mu/l
309.4
318.4
0.33
872
7145
(3027945) Reticulocytes/100 erythrocytes in Blood
1202
10305
1.17
5.97
2.6
3.0
%
1.6
1.7
2.05
1059
9293
(3032773) Endomysium IgG Ab [Titer] in Serum
212
1470
1.43
5.92
1.1
1.1
titre
—
53.3
—
0
6
(3017315) Amylase [Enzymatic activity/volume] in Urine
105
623
1.67
5.92
1.1
1.3
u/l
273.8
325.2
0.42
97
578
(3045414) Leukocytes [Presence] in Urine
661
5384
1.22
5.82
1.9
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
221
1550
1.42
5.81
1.1
1.2
—
—
—
0
0
(4034850)
474
3725
1.27
5.76
7.6
7.9
—
—
—
0
0
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
37
154
2.38
5.72
1.1
1.1
u/ml
23.8
24.8
—
10
29
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
37
154
2.38
5.72
1.1
1.1
u/ml
11.3
38.3
—
5
33
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
168
1123
1.49
5.69
1.2
1.3
titre
253.2
214.7
0.16
22
218
(3023323) Follitropin [Units/volume] in Serum or Plasma
1193
10266
1.16
5.66
1.4
1.4
iu/l
21.9
24.6
2.32
1030
8762
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
443
3461
1.28
5.66
1.2
1.4
u/ml
243.4
246.0
0.08
266
2166
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
73
1271
0.57
5.63
20.1
19.2
nmol/l
1381.3
2155.9
0.52
68
1231
(3017143) Hepatitis C virus Ab [Presence] in Serum
2353
21176
1.12
5.62
1.6
1.7
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
100
595
1.67
5.60
1.9
2.8
e6/l
278.4
242.5
0.50
67
332
(3033658) Prothrombin time (PT) actual/Normal
3265
29905
1.10
5.56
3.5
3.9
%
96.9
94.2
9.28
3164
29110
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
3302
30268
1.10
5.53
1.6
1.6
mmol/l
1.4
1.4
0.95
2927
26227
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
172
1163
1.47
5.52
1.1
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
4336
40253
1.09
5.51
2.1
2.0
—
—
—
0
0
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
18
51
3.50
5.50
1.0
1.0
u/ml
0.0
0.1
—
9
23
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
93
548
1.68
5.42
1.2
1.1
%
103.0
93.9
1.77
45
240
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
244
1764
1.38
5.40
1.4
1.5
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
171
1161
1.46
5.38
1.1
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1341
11683
1.15
5.38
2.7
2.5
ug/l
0.6
0.7
2.60
742
6560
(3035933) Granulocytes/100 leukocytes in Blood
92
542
1.68
5.37
1.4
1.7
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
171
1162
1.46
5.36
1.1
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
386
2992
1.28
5.28
1.3
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
1008
8611
1.17
5.27
7.1
7.9
mmol/l
1.3
1.3
0.74
965
8273
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
94
564
1.65
5.14
1.1
1.1
%
101.3
94.1
1.68
46
241
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
168
1151
1.45
5.08
1.1
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
978
8363
1.17
5.06
2.9
3.7
mmol/l
1.2
1.2
0.14
891
7363
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
179
1243
1.43
5.04
1.3
1.3
umol/l
4.9
5.7
2.28
167
1151
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
168
1153
1.45
5.03
1.1
1.2
—
—
—
0
0
(4094501)
355
2743
1.29
5.00
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
167
1149
1.44
4.95
1.1
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
273
2041
1.33
4.90
1.7
1.7
titre
580.0
2338.1
—
8
75
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
453
3616
1.25
4.88
1.8
2.0
iu/l
23.5
8.6
0.36
170
1454
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
95
582
1.62
4.81
1.1
1.2
%
121.6
106.8
3.78
89
523
(3003740) Influenza virus B Ag [Presence] in Specimen
395
3109
1.26
4.81
1.1
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
95
583
1.62
4.78
1.8
1.6
u/field
2.1
3.1
0.68
57
433
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
68
382
1.77
4.75
1.1
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
39
181
2.14
4.73
1.7
2.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
117
756
1.54
4.73
1.9
2.0
u/field
1.3
1.9
0.84
49
368
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
488
3947
1.23
4.68
1.9
1.8
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
29
119
2.42
4.67
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
541
4423
1.22
4.67
2.6
2.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
72
414
1.73
4.65
1.6
1.5
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
321
2474
1.29
4.64
1.9
1.9
titre
1.6
7.5
—
5
53
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
1222
10691
1.14
4.64
2.3
2.3
u/l
6379.3
6331.9
0.01
451
4218
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
68
385
1.75
4.63
2.3
3.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
812
6896
1.17
4.61
2.1
2.2
ug/l
6.6
7.4
0.49
698
6095
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
325
2512
1.29
4.60
1.5
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
1871
16809
1.12
4.60
1.9
1.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1565
13924
1.13
4.56
5.2
6.5
mmol/l
1.1
1.1
0.15
1454
13114
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
240
1783
1.34
4.53
1.6
1.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1345
11864
1.13
4.51
6.9
7.6
mmol/l
104.8
104.6
0.82
1330
11641
(3002523) Influenza virus A Ag [Presence] in Specimen
392
3114
1.25
4.45
1.1
1.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1771
15895
1.12
4.43
2.1
2.5
s
29.6
29.6
0.03
1702
15439
(3022621) pH of Urine by Test strip
883
7575
1.16
4.42
2.8
2.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1528
13602
1.12
4.42
2.4
2.9
umol/l
6.5
7.0
0.44
1308
11631
(3016244) Insulin [Units/volume] in Serum or Plasma
187
1342
1.38
4.42
3.0
3.3
mu/l
35.3
26.4
1.05
174
1272
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
113
742
1.51
4.29
1.9
2.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
1026
8922
1.15
4.28
2.5
2.4
ml/min/173m2
75.6
74.7
0.31
417
3237
(3037121) Protein [Mass/volume] in Urine
478
3902
1.22
4.23
3.1
3.6
g/l
0.3
0.3
0.56
177
1851
(3023511) Choriogonadotropin [Units/volume] in Urine
661
5561
1.18
4.23
1.4
1.3
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
179
1286
1.38
4.22
1.9
2.6
%
45.0
43.2
0.21
19
162
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
191
1387
1.37
4.22
1.4
1.3
nmol/l
20.7
30.6
—
7
17
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
222
1650
1.34
4.21
1.2
1.3
nmol/l
0.5
1.5
0.76
215
1598
(3008757) Leukocyte morphology finding [Identifier] in Blood
159
1121
1.41
4.19
2.9
3.5
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
93
589
1.57
4.16
1.8
1.9
%
129.9
150.0
2.02
86
557
(3016502) Oxygen saturation in Arterial blood
1034
9015
1.15
4.16
7.2
8.4
%
95.8
96.1
0.56
989
8663
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
151
1058
1.42
4.13
1.4
1.3
pmol/l
589.1
93.4
0.45
49
306
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
71
422
1.67
4.11
1.2
1.1
u/ml
69.8
54.6
0.95
71
410
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1232
10884
1.13
4.05
3.6
4.4
u/l
227.4
237.4
2.31
1164
10347
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
96
617
1.54
4.04
2.5
3.1
ug/l
1.0
1.4
1.09
86
588
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1160
10213
1.13
4.03
2.5
2.5
g/l
0.2
0.2
4.71
1083
9592
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
770
6587
1.17
4.03
2.6
2.8
ng/l
102.7
146.3
4.68
664
5895
(3045424) Erythrocytes [Presence] in Urine
264
2029
1.29
3.97
1.4
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
200
1480
1.34
3.94
1.2
1.3
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
40
202
1.96
3.94
2.0
2.0
pmol/l
65.0
39.7
0.36
35
175
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
220
1652
1.32
3.92
1.2
1.3
nmol/l
0.1
0.2
—
8
87
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
688
5857
1.17
3.85
5.0
5.5
mmol/l
24.2
24.0
0.48
620
5387
(3014271) Vancomycin [Susceptibility]
52
289
1.78
3.84
2.6
2.8
—
—
—
0
0
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
14
43
3.23
3.83
1.0
1.0
u/ml
0.0
0.1
—
6
16
(4146454)
123
843
1.45
3.82
3.2
2.7
—
—
—
0
0
(3033942) Copper [Moles/time] in 24 hour Urine
20
76
2.61
3.81
1.0
1.4
umol/24h
0.2
0.9
—
9
39
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
59
341
1.72
3.81
1.2
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
6248
59450
1.07
3.80
3.8
3.9
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
1156
10221
1.13
3.77
7.0
7.9
kpa
12.7
13.3
3.84
1095
9770
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1156
10227
1.13
3.74
7.0
7.9
kpa
5.0
5.1
1.41
1097
9774
(3028626) Oxygen [Partial pressure] in Capillary blood
413
3369
1.22
3.73
4.5
5.4
kpa
9.1
9.1
0.02
396
3176
(3000475) Leukocytes [#/volume] in Synovial fluid
293
2302
1.27
3.72
1.7
1.7
e6/l
11333.0
11833.7
0.07
219
1699
(3028300) Cannabinoids [Presence] in Urine
1192
10571
1.13
3.71
1.9
2.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
396
3219
1.22
3.70
2.3
2.4
ug/l
356.0
528.7
0.57
350
2957
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
31
146
2.10
3.70
2.8
2.7
pmol/l
43.1
65.8
1.26
26
123
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
309
2446
1.26
3.69
1.6
1.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
73
451
1.61
3.67
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
1189
10549
1.13
3.67
1.9
2.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
361
2913
1.23
3.63
1.2
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
153
1103
1.38
3.60
1.2
1.2
—
—
—
0
0
(44790047)
180
1332
1.34
3.59
1.5
1.6
—
—
—
0
0
(44790049)
180
1332
1.34
3.59
1.5
1.6
—
—
—
0
0
(44790048)
180
1333
1.34
3.57
1.5
1.6
—
—
—
0
0
(44806118)
180
1333
1.34
3.57
1.5
1.6
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
141
1915
0.73
3.53
3.5
3.7
u/ml
34.2
28.2
0.19
136
1850
(3000991) Gas panel - Venous blood
1018
8973
1.13
3.51
7.9
9.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
1178
10479
1.12
3.49
1.9
2.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
394
3224
1.22
3.48
1.5
1.5
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
108
739
1.45
3.43
1.5
1.6
u/l
4.8
6.1
3.22
88
629
(3006184) Hemoglobin [Mass/volume] in Capillary blood
292
2319
1.25
3.42
1.9
2.1
g/l
133.1
132.5
0.17
194
1739
(3033923) Metanephrine [Moles/time] in 24 hour Urine
40
213
1.86
3.42
1.0
1.1
umol/24h
0.7
1.0
0.41
24
107
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
311
2488
1.24
3.41
1.4
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
306
2444
1.24
3.41
3.5
3.0
mg/l
25.2
25.5
0.04
168
1481
(3003694) ABO and Rh group [Type] in Blood
4103
42704
0.93
3.40
1.6
1.6
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
91
604
1.49
3.37
2.4
2.2
mg/l
9.6
9.5
0.07
70
494
(3006462) Nitrate [Presence] in Urine
85
557
1.51
3.35
3.3
2.7
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
75
478
1.56
3.35
1.8
1.8
au/ml
59.3
136.7
—
7
66
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
373
3049
1.22
3.34
1.7
1.7
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
498
4183
1.18
3.33
3.2
3.6
mmol/l
25.5
25.2
1.46
481
4046
(3036071) Salmonella sp Ab [Titer] in Serum
79
511
1.53
3.31
1.1
1.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
41
223
1.82
3.29
1.8
1.6
ug/l
0.4
0.5
0.27
27
152
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
191
1446
1.31
3.29
1.2
1.3
nmol/l
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
95
640
1.47
3.28
1.9
1.7
nmol/l
2.4
15.1
0.81
74
534
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
270
2138
1.25
3.26
2.5
3.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
1635
14859
1.10
3.25
1.9
1.9
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
59
358
1.63
3.24
1.2
1.1
%
74.7
72.2
0.12
12
84
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
331
2685
1.23
3.22
3.3
3.7
%
55.5
56.5
0.97
331
2685
(1001926) Buprenorphine [Presence] in Urine by Screen method
926
8163
1.13
3.21
2.1
2.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
447
3734
1.19
3.20
1.2
1.3
titre
1495.6
996.6
—
9
104
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
44
247
1.77
3.20
1.0
1.1
—
—
—
0
0
(4211845)
91
612
1.48
3.18
3.3
2.6
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
57
345
1.64
3.16
1.7
2.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
399
3304
1.20
3.15
2.1
2.4
umol/l
6.4
6.1
0.07
300
2442
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
164
1224
1.33
3.14
1.5
1.7
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
69
439
1.56
3.13
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
69
439
1.56
3.13
1.3
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
831
7290
1.14
3.13
2.3
2.8
e9/l
68.5
71.1
1.45
613
5309
(3022217) INR in Platelet poor plasma by Coagulation assay
1173
10508
1.11
3.10
16.8
16.7
inr
1.2
1.2
0.36
170
1713
(3050794) Legionella sp Ab [Presence] in Serum
21
91
2.29
3.09
1.3
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
102
707
1.43
3.07
2.7
3.1
au/ml
106.3
148.4
0.36
12
97
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
119
850
1.39
3.02
1.5
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
119
850
1.39
3.02
1.5
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
119
850
1.39
3.02
1.5
1.7
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
374
3092
1.20
3.02
1.2
1.5
mmol/l
3.6
3.6
1.03
356
2903
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
178
1354
1.31
3.00
1.5
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
136
995
1.36
2.99
1.1
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
161
1209
1.32
2.97
1.6
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
1160
10413
1.11
2.96
1.8
2.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
44
254
1.72
2.93
1.4
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
32
168
1.89
2.90
1.7
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
815
7189
1.13
2.84
2.9
2.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
2012
18568
1.08
2.84
2.1
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
1087
9749
1.11
2.83
2.0
2.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
272
2196
1.23
2.82
3.3
3.1
mg/l
28.9
46.1
1.49
226
1758
(3034860) Kappa light chains.free [Mass/volume] in Serum
272
2197
1.23
2.81
3.3
3.1
mg/l
35.5
74.0
0.84
226
1757
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
415
3490
1.18
2.80
1.3
1.5
mg/l
417.6
473.9
2.05
399
3327
(3021901) Oxygen saturation in Capillary blood
215
1693
1.26
2.79
2.4
3.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
225
1783
1.25
2.77
1.8
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
130
958
1.35
2.76
1.2
1.2
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
9
23
3.88
2.74
1.0
1.0
—
—
—
0
0
(4024509)
130
960
1.34
2.72
1.6
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
398
3344
1.18
2.72
1.3
1.5
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
57
360
1.57
2.71
1.2
1.1
%
83.1
83.4
—
9
89
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
496
4246
1.16
2.70
4.2
3.8
%
0.7
0.7
1.59
475
4082
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
108
777
1.38
2.68
3.9
3.7
mg/l
8.2
8.3
0.08
93
627
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
77
521
1.47
2.67
1.6
1.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
2193
20357
1.08
2.67
1.7
1.7
%
1.4
1.4
0.53
1954
18398
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
187
1459
1.27
2.64
1.3
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
806
7142
1.12
2.63
1.3
1.3
miu/ml
237.7
226.5
0.37
399
3457
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
263
2135
1.22
2.61
3.1
3.0
ratio
1.5
2.2
0.53
34
212
(3007566) Smooth muscle Ab [Titer] in Serum
450
3834
1.17
2.61
1.2
1.3
titre
94.1
115.1
0.47
51
384
(3049717) Cytology report of Urine Cyto stain
313
2586
1.20
2.60
2.3
2.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
262
3148
0.82
2.59
2.9
3.6
u/ml
142.4
1697.4
1.06
230
2694
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
80
550
1.44
2.57
1.2
1.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
196
1545
1.26
2.55
1.7
1.6
iu/ml
45.7
32.8
—
10
78
(3018405) Lactate [Moles/volume] in Arterial blood
368
3092
1.18
2.54
4.2
4.0
mmol/l
1.4
1.4
0.10
358
3038
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
48
296
1.61
2.54
1.4
1.7
—
—
—
0
0
(4281824)
93
1271
0.72
2.54
1.1
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
191
1503
1.26
2.53
1.6
1.6
mmol/l
67.7
67.4
0.02
142
1198
(3003396) Base excess in Arterial blood by calculation
1132
10240
1.10
2.53
7.1
7.9
mmol/l
0.8
0.8
0.13
884
7904
(3002814) Trichinella spiralis Ab [Titer] in Serum
6
11
5.40
2.52
1.2
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
276
2261
1.21
2.52
1.1
1.1
iu/ml
130.8
4729.5
0.63
72
576
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
76
520
1.45
2.51
1.6
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
76
520
1.45
2.51
1.6
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
76
520
1.45
2.51
1.6
1.9
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
22
107
2.04
2.50
1.0
1.1
umol/24h
1.5
1.8
1.06
22
107
(3008295) Osmolality of Serum or Plasma
147
1121
1.30
2.50
2.0
1.7
mosm/kgh2o
282.7
282.8
0.00
114
878
(3037556) Urate [Mass/volume] in Serum or Plasma
42
252
1.65
2.48
1.1
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
81
563
1.43
2.47
1.3
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
226
1819
1.23
2.46
1.6
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
181
1422
1.26
2.44
1.7
1.6
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
828
7386
1.12
2.43
7.3
8.7
mmol/l
24.7
24.7
0.01
823
7343
(3004446) Plasmodium sp identified in Blood by Light microscopy
32
179
1.77
2.43
2.6
2.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
286
2364
1.20
2.40
1.7
2.5
nmol/l
0.9
0.8
0.53
239
2010
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
238
1933
1.22
2.39
1.1
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
808
8869
0.90
2.38
3.3
4.0
ug/l
31.8
23.2
0.21
612
6772
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
391
3327
1.17
2.35
1.3
1.5
u/ml
19.0
21.5
—
10
68
(40760888) Immunoglobulin light chains.free panel - Serum
208
1671
1.24
2.33
3.3
3.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
139
1064
1.30
2.32
1.6
1.7
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
486
4207
1.15
2.32
2.4
3.0
%
163.3
173.3
2.07
452
4005
(3044927) Protein electrophoresis panel - Urine
97
705
1.36
2.31
1.2
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
88
630
1.39
2.30
1.6
1.7
mmol/l
30.5
35.5
1.22
71
564
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
84
598
1.39
2.27
1.1
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
34
198
1.70
2.27
1.1
1.1
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
34
198
1.70
2.27
1.2
1.2
mg/l
0.8
94.2
1.65
27
141
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
140
1079
1.29
2.23
1.3
1.3
mmol/l
1.8
1.9
1.09
132
1004
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
81
575
1.40
2.23
1.3
1.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
484
4202
1.14
2.23
2.6
3.3
g/l
3.5
3.5
0.12
453
4001
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
11
41
2.66
2.23
1.3
2.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
155
1211
1.27
2.22
1.3
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
59
396
1.48
2.19
1.7
2.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
123
936
1.30
2.17
1.5
1.6
mmol/l
6.8
6.1
0.86
92
711
(3001019) Free T4 and TSH panel - Serum or Plasma
1085
9877
1.09
2.16
1.7
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
1313
14013
0.92
2.16
1.5
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
174
1384
1.25
2.16
1.4
2.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
42
263
1.58
2.14
1.3
1.6
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
36
217
1.64
2.13
1.3
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
290
2431
1.18
2.12
2.7
3.7
mmol/l
24.0
24.3
0.65
267
2143
(3052851) Hemolysis interference index of Serum or Plasma
393
3378
1.16
2.11
2.6
2.9
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
82
591
1.38
2.09
1.2
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
188
1515
1.23
2.08
1.1
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
154
1214
1.26
2.08
1.5
1.6
%
51.9
53.0
0.13
96
787
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
215
1759
1.21
2.06
1.6
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
57
386
1.46
2.05
1.8
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
57
386
1.46
2.05
1.8
2.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
161
1279
1.25
2.04
1.1
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
12429
121605
1.05
2.02
14.8
13.7
g/l
333.5
333.3
1.53
12346
120698
(3007930) Methemoglobin/Hemoglobin.total in Blood
411
3556
1.15
2.02
3.8
5.2
%
0.9
0.9
2.33
380
3320
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
365
3131
1.16
2.02
1.3
1.5
u/ml
118.5
107.7
0.35
68
634
(3019060) Gas panel - Arterial blood
628
5582
1.12
2.02
4.3
4.9
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
69
486
1.41
2.02
1.1
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
640
5700
1.12
1.99
1.3
1.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
196
1595
1.22
1.99
1.7
1.7
mu/l
69.3
63.8
0.13
170
1449
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
415
3598
1.15
1.99
3.8
5.1
%
1.6
1.8
4.23
382
3352
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
164
1310
1.24
1.99
1.1
1.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
14
281
0.49
1.95
1.9
2.0
e6/l
22378.6
15669.3
—
7
144
(3024869) Neuronal Ab [Presence] in Serum
28
162
1.71
1.95
1.1
1.0
—
—
—
0
0
(4035726)
856
9258
0.91
1.94
1.4
1.4
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
97
728
1.32
1.93
1.1
1.1
nmol/l
1.8
6.6
1.02
16
141
(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid
13
57
2.26
1.93
1.5
1.1
mg/l
0.0
0.1
0.47
13
48
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
362
3117
1.15
1.93
1.3
1.6
e6/l
576.6
2105.6
0.70
299
2519
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
73
525
1.38
1.91
1.2
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
1194
10991
1.08
1.87
1.4
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
626
5593
1.11
1.86
4.1
4.0
g/l
133.6
131.2
1.92
617
5469
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
361
3117
1.15
1.86
1.3
1.6
e6/l
21.8
27.5
0.21
284
2388
(3020891) Body temperature
415
3620
1.14
1.85
4.9
4.8
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
39
250
1.55
1.84
1.3
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
39
250
1.55
1.84
1.3
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
39
250
1.55
1.84
1.3
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
39
250
1.55
1.84
1.3
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
1063
11359
0.92
1.84
3.7
3.4
—
—
—
0
0
(4133840)
56
388
1.43
1.82
1.0
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
71
513
1.37
1.82
1.0
1.0
ng/l
789.2
756.2
0.30
51
353
(1761482) Bacteria [#/volume] in Urine by Culture
253
2129
1.18
1.82
4.2
3.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
104
796
1.30
1.82
1.2
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
107
1355
0.78
1.81
2.0
1.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
87
650
1.33
1.81
1.9
1.7
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
60
422
1.41
1.80
1.3
1.7
nmol/l
0.2
0.2
0.49
46
311
(3022475) Manganese [Moles/volume] in Blood
17
86
1.96
1.80
1.3
1.3
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
71
515
1.37
1.79
1.0
1.0
ng/l
40.3
41.9
0.13
53
359
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
50
341
1.45
1.78
1.4
1.6
ug/l
9.4
8.8
0.50
50
341
(3000330) Specific gravity of Urine by Test strip
554
4935
1.12
1.76
3.4
2.9
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
17
308
0.55
1.75
4.9
6.7
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
35
222
1.56
1.74
1.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
69
501
1.37
1.74
1.1
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
118
925
1.27
1.73
1.5
1.6
%
33.2
34.8
0.19
73
575
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
70
510
1.36
1.73
1.0
1.0
ng/l
302.7
326.3
0.35
53
363
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
193
1595
1.20
1.72
1.1
1.1
—
30.6
—
0
11
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
9
36
2.48
1.71
1.1
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
39
255
1.52
1.71
1.2
1.2
pmol/l
250.0
376.9
1.09
26
193
(3033799) Differential panel - Peritoneal fluid
14
267
0.52
1.71
1.5
2.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
8
30
2.64
1.70
1.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
82
615
1.32
1.68
1.2
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
184
1519
1.20
1.67
1.4
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
34
217
1.55
1.66
1.1
1.2
—
—
—
0
0
(3036489) Thrombin time
571
5114
1.11
1.66
2.1
2.6
s
21.3
21.2
0.09
473
4377
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
18
96
1.86
1.65
1.6
3.6
pmol/l
2.8
77.7
—
8
33
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
154
1253
1.22
1.63
1.1
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
24
141
1.69
1.62
1.1
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
13
62
2.08
1.61
1.0
1.0
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
9
187
0.48
1.60
1.1
1.5
%
3.7
3.4
—
9
162
(3008152) Bicarbonate [Moles/volume] in Arterial blood
609
5486
1.10
1.59
6.7
7.0
mmol/l
24.2
24.4
0.69
565
5088
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
162
1333
1.21
1.55
1.3
1.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
920
8456
1.08
1.54
7.8
8.7
g/l
124.8
122.6
2.51
889
8140
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
142
1702
0.82
1.51
2.7
3.3
u/ml
8.3
963.5
0.95
130
1564
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
45
312
1.43
1.51
1.2
1.3
nmol/l
117.8
116.2
0.03
34
238
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
5
15
3.30
1.51
1.2
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
38
255
1.48
1.50
1.1
1.1
—
—
—
0
0
(4027681)
136
1104
1.22
1.50
1.2
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
110
873
1.25
1.49
2.6
2.7
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
34
497
0.68
1.49
6.4
4.6
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
125
1007
1.23
1.49
2.1
2.7
%
100.5
96.9
0.72
120
932
(21491868) Cryoglobulin [Mass/volume] in Serum
60
439
1.35
1.48
1.1
1.2
g/l
—
0.2
—
0
28
(3023487) Leukocytes [#/volume] in Peritoneal fluid
19
316
0.59
1.48
1.7
2.2
e6/l
514.3
3461.6
0.61
14
214
(3009871) Measles virus Ab [Titer] in Serum
72
542
1.32
1.48
1.8
1.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
304
2646
1.14
1.47
4.7
4.2
mmol/l
3.8
3.8
0.63
292
2490
(3007916) DNA double strand Ab [Titer] in Serum
26
161
1.60
1.46
1.2
1.4
—
257.9
—
0
17
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
19
108
1.74
1.45
1.1
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
28
177
1.57
1.45
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
984
10432
0.93
1.45
2.9
2.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
314
3518
0.88
1.44
1.7
1.8
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
69
519
1.32
1.43
1.0
1.1
ng/l
28.6
394.3
—
7
116
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
5
16
3.10
1.42
1.0
1.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
176
1474
1.18
1.42
1.4
1.4
pmol/l
342.6
359.3
0.14
138
1154
(3017354) Segmented neutrophils/100 leukocytes in Blood
117
943
1.23
1.40
2.5
3.2
%
58.7
55.8
0.77
80
592
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
274
2380
1.14
1.38
1.1
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
33
220
1.49
1.37
1.8
2.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
263
2280
1.14
1.37
3.1
3.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
93
733
1.26
1.37
1.2
1.1
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
5
17
2.91
1.34
1.2
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
54
396
1.35
1.34
1.6
2.0
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
161
1346
1.19
1.34
1.1
1.1
mg/l
230.3
234.3
0.11
142
1186
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
530
4793
1.10
1.33
9.5
10.6
mmol/l
24.2
24.2
0.08
497
4522
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
42
2.12
1.32
1.0
1.0
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
165
1385
1.18
1.32
1.2
1.2
mg/l
34.1
39.4
1.28
141
1154
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
270
2354
1.14
1.31
1.3
1.3
u/ml
4.7
4.0
0.36
124
1064
(3033705) Calcium.ionized [Moles/volume] in Venous blood
112
907
1.22
1.30
2.5
2.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
35
239
1.45
1.30
1.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
1430
13439
1.06
1.29
1.4
1.5
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
43
306
1.39
1.29
1.2
1.1
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
6
24
2.48
1.28
1.2
1.0
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
9
170
0.52
1.28
1.1
1.5
%
20.1
26.7
—
9
156
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
8
34
2.33
1.28
1.4
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
713
7608
0.92
1.27
2.4
2.9
u/ml
35.0
41.1
0.57
690
7335
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
20
121
1.64
1.26
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
67
513
1.29
1.26
2.1
2.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
93
1137
0.81
1.26
9.5
12.1
mmol/l
0.6
0.6
0.43
83
1054
(3026250) Tacrolimus [Mass/volume] in Blood
52
683
0.75
1.25
35.6
37.7
ug/l
7.3
7.3
0.05
47
637
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
5
115
0.43
1.24
2.4
5.4
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
11
55
1.98
1.24
1.6
1.3
nmol/l
427.0
556.5
0.48
11
55
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
277
2433
1.13
1.21
1.1
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
14
77
1.80
1.21
1.1
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
18
107
1.67
1.21
1.1
1.1
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
5
19
2.61
1.20
1.2
1.5
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
5
19
2.61
1.20
1.0
1.2
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
5
19
2.61
1.20
1.2
1.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
31
211
1.46
1.19
1.1
1.8
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
12
211
0.56
1.19
2.9
3.1
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
625
5729
1.08
1.19
9.4
10.0
%
1.4
1.4
0.30
619
5693
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
120
991
1.20
1.18
1.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
142
1192
1.18
1.17
1.6
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
1864
19246
0.95
1.17
1.3
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
14
234
0.59
1.16
1.5
1.2
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
33
229
1.43
1.16
3.3
4.3
u/l
43.8
67.0
0.62
12
83
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
119
984
1.20
1.16
1.1
1.1
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
12
64
1.86
1.14
1.0
1.0
—
14.4
—
0
18
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
173
1479
1.16
1.14
1.1
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
588
5390
1.08
1.13
2.5
2.5
e6/l
0.2
0.3
0.83
567
5215
(3003434) Protein [Mass/volume] in Pleural fluid
65
814
0.79
1.12
1.4
1.5
g/l
34.6
34.6
0.00
54
741
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
294
2611
1.12
1.10
1.1
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
134
1127
1.18
1.09
1.1
1.1
mg/l
291.9
289.0
0.18
118
1027
(3039443) Prostate specific Ag panel - Serum or Plasma
196
1698
1.14
1.09
1.5
1.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
28
191
1.45
1.08
1.3
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
281
2495
1.12
1.06
1.1
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
63
492
1.27
1.06
1.4
1.5
%
7.0
3.5
—
8
119
(3028433) Virus identified in Specimen by Culture
55
422
1.29
1.06
1.3
1.2
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
27
184
1.45
1.06
1.3
1.3
titre
—
102.5
—
0
22
(3044007) Cell count panel - Peritoneal fluid
16
251
0.63
1.05
1.8
2.1
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
9
45
1.98
1.04
1.6
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
28
193
1.44
1.04
1.5
2.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
5299
51433
1.03
1.03
2.3
2.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
132
1116
1.17
1.03
2.8
3.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
38
278
1.35
1.01
3.9
9.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
168
1449
1.15
1.01
1.5
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
64
504
1.26
1.01
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
294
2628
1.11
1.00
2.4
2.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
51
647
0.78
1.00
1.5
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
98
810
1.20
0.99
1.1
1.1
miu/ml
1506.0
1464.8
0.14
98
810
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
89
1061
0.83
0.99
1.2
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
75
909
0.82
0.99
1.0
1.1
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
39
288
1.34
0.99
2.2
2.4
mmol/l
1.4
1.6
0.11
28
212
(40768795) Lymph node Pathology biopsy report
94
1113
0.84
0.98
1.2
1.2
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
28
0.00
0.97
0.0
6.2
—
587.3
—
0
23
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
28
386
0.72
0.97
2.1
1.7
—
426.1
—
0
8
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
24
163
1.46
0.97
2.6
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
176
1531
1.14
0.96
1.4
2.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
47
359
1.30
0.96
1.1
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
47
359
1.30
0.96
1.1
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
47
359
1.30
0.96
1.1
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
771
7195
1.06
0.95
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
768
7167
1.06
0.94
1.4
1.4
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
51
395
1.28
0.94
1.3
1.3
umol/l
18.1
17.1
1.06
42
357
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
3360
32434
1.03
0.93
1.7
1.7
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
51
1.75
0.93
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
1600
15238
1.04
0.91
1.2
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
71
575
1.22
0.90
1.2
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
153
1729
0.88
0.90
3.2
3.6
u/ml
2533.7
437.3
0.45
138
1586
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
431
3947
1.08
0.90
1.2
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
118
1002
1.17
0.90
1.1
1.2
ratio
1.1
1.1
0.15
35
370
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
20
133
1.49
0.90
1.8
1.8
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
54
425
1.26
0.89
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
271
2433
1.10
0.88
1.3
1.3
u/ml
3.2
3.6
0.15
95
845
(3004809) Band form neutrophils/100 leukocytes in Blood
183
1607
1.13
0.88
2.7
3.1
%
0.8
1.4
3.49
140
1264
(3051651) Icteric interference index of Serum or Plasma
89
740
1.19
0.88
2.8
3.9
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
369
3363
1.09
0.88
1.5
1.5
nmol/l
0.4
0.4
0.21
303
2684
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
68
819
0.82
0.87
1.5
1.6
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
62
498
1.23
0.86
1.4
1.5
pmol/l
14.0
14.2
0.21
52
422
(21494567) Legionella sp IgM Ab [Presence] in Serum
12
71
1.67
0.86
1.4
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
19
273
0.69
0.86
3.8
6.6
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
68
553
1.22
0.85
1.1
1.1
u/l
14.3
18.0
0.56
49
430
(3006922) Hepatitis E virus Ab [Presence] in Serum
126
1083
1.15
0.84
1.1
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
21
144
1.44
0.83
1.2
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
183
2030
0.89
0.83
5.0
5.5
umol/l
363.5
382.0
1.08
160
1798
(3023199) Leukocytes [#/volume] in Pleural fluid
63
759
0.82
0.82
1.5
1.5
e6/l
2046.7
2729.9
0.66
42
555
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
8
139
0.57
0.82
7.3
9.9
mmol/l
6.5
5.6
—
8
139
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
105
892
1.17
0.82
1.1
1.1
u/l
1.0
1.1
0.60
53
387
(3010421) pH of Blood
301
2729
1.09
0.82
3.0
3.8
ph
7.4
7.4
0.06
254
2321
(3004959) Base excess in Arterial cord blood by calculation
17
247
0.68
0.82
1.1
1.0
—
0.2
—
0
27
(3006598) pH of Arterial cord blood
17
247
0.68
0.82
1.1
1.0
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
88
737
1.18
0.82
1.9
1.8
mg/l
2.8
3.5
1.32
80
706
(3050129) First trimester maternal screen panel - Serum or Plasma
903
9389
0.95
0.81
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
768
7211
1.06
0.80
1.4
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
278
2514
1.10
0.80
1.2
1.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
20
137
1.45
0.80
1.1
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
297
2695
1.09
0.80
5.5
6.0
iu/ml
927.0
710.8
0.22
33
350
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
57
690
0.82
0.79
1.1
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
107
914
1.16
0.79
3.1
3.0
nmol/l
0.8
0.8
0.55
78
676
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
768
7216
1.06
0.79
1.4
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
141
1229
1.14
0.79
1.1
1.1
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
51
406
1.24
0.79
2.6
2.8
umol/l
28.4
28.6
0.03
38
295
(3022493) Free Hemoglobin [Mass/volume] in Plasma
43
536
0.79
0.78
8.1
5.2
mg/l
5076.3
2845.5
0.18
30
400
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
6
33
1.80
0.78
1.0
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
291
2643
1.09
0.78
1.3
1.3
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
27
197
1.36
0.78
1.1
1.6
ng/l
70.2
51.8
0.17
15
120
(40761995) Spermatozoa Progressive [#/volume] in Semen
48
590
0.81
0.77
3.4
3.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
252
2274
1.10
0.77
1.1
1.1
%
120.1
117.1
0.71
227
2084
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
70
828
0.84
0.77
1.3
1.3
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
48
589
0.81
0.76
6.8
6.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
191
1701
1.11
0.76
1.3
1.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
17
114
1.48
0.76
1.4
1.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
85
716
1.18
0.75
2.5
2.8
%
45.8
41.4
1.42
37
235
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
16
106
1.50
0.75
1.1
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
429
3968
1.07
0.74
1.7
1.8
g/l
1.4
1.4
0.47
367
3422
(3011048) Pyruvate [Moles/volume] in Blood
21
148
1.41
0.74
1.1
1.4
umol/l
96.9
86.5
0.31
21
134
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
9
54
1.65
0.74
5.6
2.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
42
330
1.26
0.73
1.9
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
34
260
1.30
0.73
1.0
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
47
375
1.24
0.73
2.1
2.0
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
14
91
1.52
0.72
1.0
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
116
1006
1.14
0.72
1.3
1.4
umol/l
9.6
11.1
2.99
111
964
(3005593) Pancreatic islet cell Ab [Titer] in Serum
7
39
1.78
0.72
1.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
25
183
1.35
0.72
1.3
1.1
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
67
556
1.19
0.71
1.1
1.1
u/l
74.2
78.2
0.26
53
452
(3035320) C reactive protein [Mass/volume] in Body fluid
106
915
1.15
0.70
2.6
2.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
134
1177
1.13
0.69
1.2
1.2
u/l
68.9
69.9
0.03
94
810
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
14
92
1.51
0.69
1.1
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
57
678
0.83
0.69
1.4
1.4
e6/l
102682.2
55111.9
0.28
29
399
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
7
41
1.69
0.69
1.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
55
450
1.21
0.68
1.1
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
172
1888
0.90
0.68
1.2
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
27
202
1.32
0.68
2.0
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
84
716
1.16
0.67
1.3
1.7
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
20
270
0.73
0.67
1.3
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
63
524
1.19
0.67
1.4
1.6
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
92
0.54
0.66
1.4
1.4
umol/24h
189.4
326.9
—
5
92
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
184
1651
1.10
0.66
1.2
1.1
%
94.7
95.4
0.11
168
1567
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
88
754
1.16
0.66
1.2
1.1
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
11
69
1.58
0.66
1.5
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
14
199
0.70
0.64
10.1
7.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
70
810
0.86
0.64
6.3
6.9
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
54
639
0.84
0.63
1.4
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
71
601
1.17
0.63
1.4
1.3
nmol/l
131.7
135.1
0.28
71
601
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
160
1431
1.11
0.63
1.3
1.2
u/l
23.9
31.1
0.70
144
1252
(3038071) Oxygen [Partial pressure] in Mixed venous blood
19
255
0.74
0.62
3.8
6.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
246
2639
0.92
0.62
3.1
4.6
u/ml
0.4
0.3
0.33
144
1469
(3000093) Morphology [Interpretation] in Blood Narrative
112
982
1.13
0.62
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
141
1254
1.11
0.62
1.2
1.6
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
19
253
0.74
0.60
1.9
2.1
ug/l
1.6
3.3
0.89
12
159
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
21
0.00
0.60
0.0
1.2
—
3230.4
—
0
21
(3017461) Flecainide [Moles/volume] in Serum or Plasma
8
51
1.55
0.60
1.5
2.1
umol/l
0.5
0.6
—
8
40
(3012565) Volume of 24 hour Urine
64
541
1.17
0.59
1.8
2.1
ml
2120.1
2014.3
0.34
58
501
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
1661
15996
1.03
0.59
1.7
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
124
1099
1.12
0.58
1.1
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
257
2361
1.08
0.58
3.0
3.9
mmol/l
2.2
2.3
0.08
145
1555
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
812
7721
1.04
0.57
1.5
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
104
914
1.13
0.57
1.1
1.3
g/l
1.4
1.4
—
9
46
(3013166) Neutrophils/100 leukocytes in Synovial fluid
36
289
1.23
0.56
1.3
1.4
%
48.8
50.2
0.07
31
250
(3044009) aPTT.lupus sensitive (LA screen)
20
148
1.34
0.56
1.3
1.2
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
89
775
1.14
0.56
1.9
1.9
g/24h
0.8
1.3
—
8
66
(3045788) Cell count panel - Pleural fluid
52
608
0.85
0.56
1.6
1.5
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
31
245
1.25
0.55
1.3
1.2
g/l
41.8
39.0
0.54
23
128
(3016018) Differential panel - Cerebral spinal fluid
176
1596
1.09
0.55
1.2
1.7
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
103
908
1.12
0.54
1.4
1.4
e6/l
90867.9
71187.8
0.10
71
627
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
234
2149
1.08
0.54
2.2
2.5
ug/min
121.2
109.9
0.12
139
1371
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
172
1559
1.09
0.54
1.4
1.4
mmol/l
10.6
11.9
0.83
36
269
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
8
125
0.63
0.54
1.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
6
39
1.52
0.52
3.8
4.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
6
39
1.52
0.52
2.3
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
59
502
1.16
0.52
2.1
2.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
22
168
1.30
0.51
1.4
1.4
nmol/l
21.6
16.8
—
5
53
(3023183) Ammonium ion [Moles/volume] in Plasma
209
2233
0.93
0.51
2.9
3.1
umol/l
34.6
34.8
0.02
182
1952
(4306422)
259
2395
1.07
0.51
1.2
1.2
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
84
735
1.13
0.51
1.0
1.0
%
99.5
94.1
0.92
73
598
(40767503) Oxygen content in Capillary blood by calculation
230
2119
1.08
0.51
2.3
2.4
%
17.2
17.0
0.35
111
1056
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
25
311
0.80
0.50
1.1
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
15
108
1.38
0.50
1.4
2.3
u/field
1.1
0.7
0.48
15
108
(3006270) Folate [Moles/volume] in Blood
99
877
1.12
0.50
1.2
1.1
nmol/l
384.9
399.5
0.29
86
806
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
23
288
0.79
0.49
2.3
2.7
—
—
—
0
0
(44806071)
26
205
1.26
0.49
1.1
1.1
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
17
126
1.34
0.49
1.7
1.7
mmol/l
216.6
170.5
0.72
17
118
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
488
4612
1.05
0.48
2.2
3.1
%
94.7
94.1
0.25
456
4289
(40762365) Oxygen content in Arterial blood by calculation
10
142
0.70
0.48
2.1
2.6
ml/dl
14.5
14.9
—
10
131
(3036603) Volume of Urine
81
712
1.13
0.47
1.8
1.6
ml
2530.7
2066.0
0.66
13
127
(3025130) Human papilloma virus identified in Specimen
285
2658
1.06
0.46
1.7
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
267
2811
0.94
0.46
1.3
1.3
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
82
0.60
0.45
2.8
5.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
58
657
0.87
0.45
1.1
1.2
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
31
253
1.21
0.44
1.1
1.4
%
50.8
39.1
0.64
18
180
(3000012) Reticulocyte production index
41
476
0.85
0.44
1.2
1.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
34
401
0.84
0.43
2.2
2.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
337
3167
1.05
0.43
1.3
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
79
699
1.12
0.43
1.1
1.1
iu/ml
215.8
182.5
0.26
79
694
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
6
91
0.65
0.42
1.2
1.4
—
—
—
0
0
(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline
0
16
0.00
0.41
0.0
1.1
—
206.0
—
0
16
(3024932) HLA-DR beta [Type]
42
483
0.86
0.41
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
43
493
0.86
0.40
1.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
8
59
1.34
0.40
1.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
23
184
1.24
0.40
1.2
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
70
1.41
0.40
1.4
1.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
8
60
1.32
0.39
1.1
1.3
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
62
544
1.13
0.39
2.7
2.4
umol/l
71.3
71.4
—
7
83
(3035880) pH of Pleural fluid
29
343
0.84
0.39
1.2
1.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
50
565
0.88
0.39
1.7
1.8
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
152
1398
1.08
0.39
3.6
4.6
u/ml
79.3
98.0
0.21
34
457
(3046861) Legionella sp Ag [Presence] in Urine
5
35
1.41
0.39
1.4
1.0
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
70
620
1.12
0.39
2.0
1.9
nmol/l
1.5
1.3
0.73
51
499
(3010375) cycloSPORINE [Mass/volume] in Blood
58
648
0.89
0.38
24.1
27.9
ug/l
110.9
123.3
0.79
50
543
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
9
65
1.37
0.38
4.7
4.8
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
335
3478
0.95
0.38
1.2
1.2
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
5
36
1.38
0.38
1.2
1.3
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
9
67
1.33
0.37
3.3
3.1
—
0.0
—
0
10
(3009677) Dengue virus Ab [Presence] in Serum
10
71
1.39
0.37
1.4
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
17
211
0.80
0.36
1.4
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
33
278
1.18
0.36
1.3
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
47
408
1.14
0.36
1.0
1.0
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
6
41
1.45
0.35
1.3
3.0
mmol/l
4.2
4.6
—
6
41
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
6
41
1.45
0.35
5.2
5.6
mmol/l
0.2
0.2
—
6
41
(3001729) Color of Synovial fluid
5
79
0.63
0.35
1.8
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
195
2048
0.94
0.35
2.5
2.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
29
243
1.18
0.34
1.1
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
49
548
0.89
0.34
1.1
1.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
58
513
1.12
0.34
2.1
2.1
%
8.6
8.6
0.00
58
501
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
3004
29362
1.02
0.34
1.5
1.5
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
26
216
1.19
0.34
1.7
3.9
mmol/l
1.2
1.2
0.06
26
200
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
110
1177
0.92
0.33
1.6
1.7
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
60
661
0.90
0.33
2.8
2.5
umol/l
56.9
53.5
0.42
51
580
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
223
2328
0.95
0.33
1.4
1.4
mmol/l
6.6
6.9
0.48
161
1679
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
54
477
1.12
0.33
1.5
1.6
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
16
126
1.26
0.33
1.3
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
31
357
0.86
0.33
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
617
5929
1.03
0.32
1.4
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
229
2158
1.05
0.31
5.8
4.7
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
34
386
0.87
0.30
1.3
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
13
162
0.79
0.30
4.2
7.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
91
832
1.08
0.30
1.2
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
12
151
0.79
0.30
2.0
2.5
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
14
110
1.26
0.29
1.1
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
19
226
0.83
0.29
1.1
1.0
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
220
2075
1.05
0.29
2.9
3.8
u/ml
42497.8
1326.2
0.47
13
114
(3029396) Erythrocyte agglutination [Presence] in Blood
68
736
0.91
0.28
3.2
3.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
129
1.23
0.28
1.3
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
53
580
0.90
0.28
1.2
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
21
175
1.19
0.27
1.2
1.4
—
—
—
0
0
(4198724)
121
1124
1.07
0.27
2.0
2.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
42
371
1.12
0.27
2.4
2.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
11
138
0.79
0.27
1.4
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
8
65
1.22
0.27
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
128
1346
0.94
0.26
1.6
1.8
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
25
213
1.16
0.26
1.4
1.7
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
5
71
0.70
0.26
1.0
1.0
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
50
546
0.91
0.26
1.3
1.3
u/l
1258.0
394.4
0.67
43
527
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
18
149
1.20
0.25
1.3
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
13
158
0.81
0.25
2.2
3.1
u/l
9725.2
2323.1
0.37
13
148
(3020191) Ethanol [Moles/volume] in Serum or Plasma
131
1225
1.06
0.25
1.5
1.5
promille
1.4
1.3
0.28
101
920
(3034426) Prothrombin time (PT)
50
544
0.91
0.24
1.2
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
188
1949
0.95
0.24
1.4
1.5
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
10
77
1.29
0.24
1.0
1.1
mg/l
9.9
11.5
—
10
68
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
52
469
1.10
0.24
1.5
1.6
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
74
679
1.08
0.24
1.3
1.2
u/l
79.1
85.8
0.32
68
600
(3014891) Appearance of Pleural fluid
9
76
1.17
0.24
2.0
1.7
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
39
347
1.11
0.23
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
207
1966
1.04
0.23
1.6
1.7
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
5
38
1.30
0.23
1.0
2.3
mu/l
1.4
2.5
—
5
38
(3034614) HLA Ag [Interpretation]
5
39
1.27
0.22
1.2
1.2
—
—
—
0
0
(40763791) Oxygen content in Venous blood by calculation
5
40
1.24
0.22
2.2
7.8
ml/dl
13.0
12.7
—
5
34
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
48
435
1.09
0.21
1.8
1.8
—
—
—
0
0
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
345
3519
0.97
0.21
1.4
1.5
pmol/l
92.2
106.1
0.39
335
3429
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
39
350
1.10
0.21
1.1
1.1
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
14
116
1.20
0.20
2.4
2.8
—
—
—
0
0
(3038702) Sodium [Moles/volume] in Capillary blood
0
14
0.00
0.20
0.0
3.3
—
139.4
—
0
14
(3032352) Blasts [#/volume] in Cerebral spinal fluid
14
164
0.85
0.20
1.1
3.9
—
—
—
0
0
(3016750) Collection duration of Urine
49
526
0.92
0.19
2.1
2.2
min
519.0
501.2
0.67
35
424
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
24
210
1.13
0.19
6.2
3.7
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
26
229
1.12
0.19
1.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
29
319
0.90
0.19
1.5
1.4
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
880
8855
0.98
0.18
7.5
8.5
mmol/l
7.8
7.9
0.23
842
8526
(3019977) pH of Arterial blood
44
473
0.92
0.18
1.5
2.7
ph
7.4
7.4
0.02
11
139
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
63
667
0.94
0.18
1.6
2.4
umol/l
125.7
164.5
0.67
36
330
(3004775) Volume in Urine collected for unspecified duration
64
677
0.94
0.18
2.2
2.3
ml
728.6
635.4
0.98
43
505
(3017704) Immunofixation for Urine
42
382
1.09
0.18
1.7
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
661
6665
0.98
0.18
1.9
1.9
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
11
90
1.21
0.17
1.3
1.1
u/l
22.7
26.7
—
6
60
(3013727) Leukocytes other/100 leukocytes in Blood
38
345
1.09
0.17
4.6
3.3
%
49.6
50.0
0.04
38
334
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
19
165
1.14
0.17
1.1
1.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
16
182
0.87
0.17
1.7
4.0
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
5
68
0.73
0.17
1.8
1.8
%
2.6
0.3
—
5
47
(3017509) Phencyclidine [Presence] in Urine
25
275
0.90
0.16
1.6
2.0
—
—
—
0
0
(3004451) EKG impression Narrative
41
375
1.08
0.16
1.2
1.2
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
13
150
0.86
0.16
1.1
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
8
72
1.10
0.15
1.1
1.5
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
10
82
1.21
0.15
1.0
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
93
879
1.05
0.15
1.4
1.4
umol/l
64.5
70.0
—
8
73
(3019832) Treponema pallidum Ab [Presence] in Serum
2583
25393
1.01
0.15
1.7
1.7
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
7
88
0.79
0.14
2.6
5.5
—
—
—
0
0
(4268621)
164
1677
0.97
0.14
2.3
2.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
182
1857
0.97
0.14
6.6
4.8
%
64.8
65.7
0.23
182
1849
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
48
446
1.07
0.14
4.1
3.2
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
40
369
1.07
0.13
3.3
2.7
mmol/l
2.7
2.7
0.06
34
336
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
75
779
0.95
0.13
1.6
1.7
iu/ml
2513104.0
1528309.9
—
5
54
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
75
708
1.05
0.13
1.5
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
30
274
1.08
0.13
1.0
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
30
274
1.08
0.13
1.5
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
29
311
0.92
0.12
1.4
1.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
30
321
0.93
0.12
2.6
1.6
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
358
3612
0.98
0.12
1.2
1.3
ug/l
3.9
3.8
0.05
331
3318
(3005082) Progesterone [Moles/volume] in Serum or Plasma
139
1420
0.97
0.12
1.4
1.4
nmol/l
31.9
31.5
0.07
127
1308
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
38
352
1.07
0.12
1.1
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
130
1248
1.03
0.11
6.5
6.8
mg/l
11.0
10.8
0.24
121
1163
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
13
113
1.14
0.11
2.9
2.8
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
106
1014
1.04
0.11
1.3
1.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
35
324
1.07
0.11
1.1
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
89
849
1.04
0.11
1.0
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
594
5808
1.01
0.11
1.4
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
16
176
0.90
0.11
1.2
1.3
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
12
104
1.14
0.11
2.3
2.3
ug/l
2.7
4.5
—
7
37
(3023383) Lactate [Moles/volume] in Pleural fluid
18
196
0.91
0.10
1.2
1.3
mmol/l
4.7
3.5
0.37
13
179
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
17
152
1.11
0.10
1.3
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
26
239
1.08
0.10
1.2
1.4
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
5
43
1.15
0.10
1.0
1.2
nmol/l
386.2
278.1
—
5
43
(3020123) Porphyrins [Interpretation] in Serum or Plasma
10
86
1.15
0.09
1.3
1.1
—
—
—
0
0
(3013762) Body weight Measured
5
47
1.05
0.09
1.0
1.1
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
5
48
1.03
0.09
2.8
2.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
98
1000
0.97
0.09
1.2
1.2
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
78
799
0.97
0.09
1.1
1.2
u/ml
11.9
13.8
—
7
101
(3005033) Fetal Nuchal fold Thickness US
592
5801
1.01
0.09
1.4
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
45
425
1.05
0.08
2.2
2.0
ug/min
133.3
151.6
—
8
96
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
325
3172
1.01
0.08
2.0
2.0
ug/l
1.2
2.1
2.41
285
2846
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
14
125
1.11
0.08
1.1
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
208
2098
0.98
0.08
1.5
1.6
mmol/l
7.3
7.6
0.80
128
1270
(21494890) Protein electrophoresis panel - 24 hour Urine
77
738
1.03
0.08
2.4
1.9
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
69
660
1.04
0.08
1.3
1.2
u/l
22.1
18.7
0.20
64
572
(40768793) Breast Pathology biopsy report
297
2899
1.01
0.08
1.2
1.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
91
927
0.97
0.08
2.9
2.8
mg/l
48.6
59.6
0.23
62
677
(4212803)
7
66
1.05
0.08
1.0
1.1
—
—
—
0
0
(3049233) Organic acids panel - Urine
7
68
1.02
0.07
1.0
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
6
71
0.84
0.07
1.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
91
926
0.97
0.07
6.6
5.5
%
11.3
11.3
0.01
91
926
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
15
162
0.92
0.07
1.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
15
136
1.09
0.07
1.3
1.6
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
9
85
1.05
0.07
1.0
1.1
u/l
7.8
12.3
—
9
85
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
37
350
1.05
0.07
1.2
1.1
—
—
—
0
0
(3025315) Body weight
8
94
0.84
0.06
3.4
3.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
23
214
1.06
0.06
1.4
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
26
272
0.95
0.06
1.2
1.3
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
28
292
0.95
0.06
2.5
2.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
90
913
0.98
0.06
1.2
1.2
—
—
—
0
0
(4038314)
19
176
1.07
0.06
1.0
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
378
3777
0.99
0.05
4.3
6.5
mg/l
1.3
1.3
0.38
356
3579
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
54
551
0.97
0.05
1.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
75
725
1.02
0.05
1.1
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
24
250
0.95
0.05
1.6
1.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
28
290
0.96
0.05
1.5
2.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
28
290
0.96
0.05
1.5
2.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
97
942
1.02
0.05
1.2
1.3
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
63
640
0.97
0.05
1.3
1.4
mmol/l
6.7
6.1
0.69
55
592
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
55
560
0.97
0.05
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
75
726
1.02
0.05
1.2
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
20
187
1.06
0.05
1.9
2.3
mmol/l
6.9
7.6
0.58
13
101
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
511
5027
1.01
0.04
8.7
10.6
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
41
419
0.97
0.04
1.2
1.3
u/l
13.6
12.9
0.07
36
388
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
20
188
1.05
0.04
5.3
5.1
ug/min
32.9
41.7
0.29
11
133
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
17
159
1.06
0.03
1.1
1.4
%
55.0
57.9
—
6
79
(3051101) Glucose [Moles/volume] in Cord blood
14
130
1.07
0.03
5.4
6.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
70
706
0.98
0.03
1.5
1.6
u/l
5.8
4.8
0.18
34
347
(3040151) Glucose [Moles/volume] in Capillary blood
124
1214
1.01
0.03
4.5
4.3
mmol/l
7.4
7.3
0.12
100
996
(3032868) Hemoglobin electrophoresis panel in Blood
16
167
0.95
0.03
1.6
1.6
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
63
635
0.98
0.02
6.1
6.3
u/ml
33.5
6154.8
—
8
132
(3045142) Bone marrow Pathology biopsy report
101
1012
0.99
0.02
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
603
5952
1.00
0.02
1.5
1.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
43
435
0.98
0.02
2.3
2.8
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
208
2073
0.99
0.02
4.8
7.0
mmol/l
105.6
105.4
0.40
185
1853
(3039000) Anion gap in Blood
208
2072
0.99
0.02
4.8
7.0
mmol/l
11.6
11.3
1.02
185
1852
(3047181) Lactate [Moles/volume] in Blood
317
3126
1.00
0.01
4.3
5.6
mmol/l
1.2
1.3
0.24
277
2743
(3034092) Cytoplasmic Ig cells/100 cells in Blood
21
201
1.03
0.01
3.9
6.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
10
93
1.06
0.01
2.4
2.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
10
93
1.06
0.01
1.2
1.1
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
24
244
0.97
0.01
1.4
3.9
mmol/l
1.2
1.2
0.01
24
229
(3007463) Buprenorphine [Presence] in Urine
10
105
0.94
0.01
3.7
5.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
48
469
1.01
0.00
1.5
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
48
469
1.01
0.00
1.5
2.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
12
113
1.05
0.00
1.0
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
12
121
0.98
0.00
1.0
1.0
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
11
107
1.02
0.00
1.0
1.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
34
334
1.01
0.00
1.1
1.1
—
176.0
—
0
15
(40768441) Liver Pathology biopsy report
97
959
1.00
0.00
1.3
1.4
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
45
442
1.01
0.00
1.2
1.3
%
28.4
13.1
—
5
60
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
73
722
1.00
0.00
1.3
1.3
%
38.3
75.4
—
7
79
(21494434) Karyotype in Bone marrow
76
752
1.00
0.00
1.3
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
19
192
0.98
0.00
1.0
1.1
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
49
487
1.00
0.00
2.0
2.3
ng/l
154.9
120.7
1.04
34
325
(3016273) Islet cell 512 Ab [Units/volume] in Serum
18
180
0.99
0.00
1.0
1.0
—
—
—
0
0
(44806420)
15
152
0.98
0.00
2.3
2.2
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
17
170
0.99
0.00
1.2
1.2
mmol/l
7.2
7.3
—
5
41
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
20
193
1.03
0.00
1.0
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
6
65
0.91
0.00
2.3
2.1
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
9
98
0.91
0.00
1.0
1.1
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
7
74
0.94
0.00
1.1
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
5
59
0.84
0.00
1.2
1.9
—
—
—
0
0
(3028468) Fragments [Presence] in Blood by Light microscopy
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.0
—
32.1
—
0
9
(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
0
8
0.00
0.00
0.0
1.0
—
21.3
—
0
8
(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.2
—
87.8
—
0
6
(3012864) Amino acids [Identifier] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
5
52
0.95
0.00
1.2
1.1
—
—
—
0
0
(3030703) Everolimus [Mass/volume] in Blood
0
5
0.00
0.00
0.0
15.2
—
6.1
—
0
5
(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid
0
9
0.00
0.00
0.0
7.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
9
89
1.00
0.00
1.2
1.2
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
5
50
0.99
0.00
1.6
1.2
—
—
—
0
0
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009179) Lactate [Moles/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.0
—
2.0
—
0
6
(3027974) Hepatitis B virus e Ag [Presence] in Serum
8
84
0.94
0.00
2.0
1.8
—
—
—
0
0
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(36304079) Mucus [Presence] in Urine sediment
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
7
78
0.89
0.00
1.1
1.2
—
—
—
0
0
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
6
0.00
0.00
0.0
8.2
—
3.7
—
0
6
(3043614) Bacteria identified in Aspirate by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
8
84
0.94
0.00
1.6
1.2
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
8
82
0.97
0.00
2.0
1.7
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint ALLERG_RHINITIS and mortality.

Females

Parameter HR [95% CI] p-value
ALLERG_RHINITIS 0.889 [0.78, 1.02] 0.088
Birth year 0.992 [0.98, 1.0] 0.076

During the follow-up period (1.1.1998 — 31.12.2019), 1381 out of 66401 females with ALLERG_RHINITIS died.

Males

Parameter HR [95% CI] p-value
ALLERG_RHINITIS 0.751 [0.66, 0.85] < 0.001
Birth year 0.99 [0.98, 1.0] 0.029

During the follow-up period (1.1.1998 — 31.12.2019), 1357 out of 66764 males with ALLERG_RHINITIS died.

Mortality risk

Mortality risk for people of age

years, who have ALLERG_RHINITIS.

N-year risk Females Males
1 0.062% 0.131%
5 0.516% 0.934%
10 1.296% 2.347%
15 2.308% 4.425%
20 3.898% 7.773%

Relationships between endpoints

Index endpoint: ALLERG_RHINITIS – Allergic rhinitis

GWS hits: 21

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data